Cardiovascular medicine Books
Springer Fachmedien Wiesbaden Aktuelle Therapieprinzipien bei der peripheren arteriellen Verschlußkrankheit: Symposium vom 25. – 28. Oktober 1990
Book SynopsisDie rasche Entwicklung, vor allem invasiver aber auch nichtinvasiver Ver fahren, bei der Therapie der peripheren arteriellen Verschlußkrankheit in den letzten Jahren macht eine aktuelle Standortbestimmung not wendig. Dies um so mehr, als die periphere arterielle Verschlußkrankheit in therapeutischer Hinsicht von verschiedenen Disziplinen (interni stische Angiologie, Gefäßchirurgie und interventionelle Radiologie) be treut wird. Es war daher sinnvoll, eine derartige Standortbestimmung unter Beteiligung erfahrener Experten aus den drei genannten Teilgebieten durchzuführen. Ziel eines dazu veranstalteten Symposiums im Herbst 1990 in Malta war es, aktuelle Therapieprinzipien im einzelnen darzustellen, ihre Bedeutung kri tisch zu werten und interdisziplinär zu diskutieren. Von einer starren Syste matik bei der Erstellung des Programms wurde dabei bewußt Abstand genommen, um den teilnehmenden Autoren möglichst große Freiheit bei der Auswahl ihres Themas zu lassen. Trotzdem, oder vielleicht gerade deswegen, kam es bei der Zusammenstellung des Programms zu einer umfassenden Darstellung der heute wichtigsten therapeutischen Prinzipien bei der peri pheren arteriellen Verschlußkrankheit. Dies wurde sowohl bei dem Sympo sium im Herbst 1990 deutlich als auch bei der Zusammenstellung dieses Buches. Der vorliegende Band enthält nicht nur die Manuskripte der einzelnen in Malta gehaltenen Vorträge, sondern auch Teile der zu diesen Vorträgen geführten Diskussionen, so daß der Leser auch über einige Fragen oder Kri tikpunkte informiert wird. Aus diesem Grund stellt das vorliegende Buch meines Erachtens eine gute 5 Vorwort Grundlage für die Beschäftigung mit der aktuellen Therapie der peripheren arteriellen Verschlußkrankheit dar.Table of ContentsDer femoro-popliteale Bypass: Venen- oder Kunststofftransplantate?.- Der femoro-crurale Bypass, Problematik und Lösungsansätze.- Adjuvante Therapie bei femoro-distaler Bypasschirurgie.- Konservative Therapie der arteriellen Verschlußkrankheit aus chirurgischer Sicht.- Perkutane transluminale Angioplastie.- Antithrombotische Therapie nach Rekanalisation und Bypassoperation bei peripherer arterieller Verschlußkrankheit.- Lokale Lyse, Atherektomie, Stent.- Chancen und Grenzen der Bewegungstherapie bei peripherer arterieller Verschlußkrankheit.- Medikamentöse Vasodilatation bei peripherer arterieller Verschlußkrankheit — Eine alte Kontroverse.- Klinische Wirksamkeit vasoaktiver Medikamente im Stadium II der peripheren arteriellen Verschlußkrankheit.- Kontrolle therapeutisch relevanter Parameter bei der Behandlung der peripheren arteriellen VerschluBkrankheit.
£42.29
Springer-Verlag Berlin and Heidelberg GmbH & Co. KG Early CT Diagnosis of Hemispheric Brain Infarction
Book SynopsisCT signs of early cerebral infarction are subtle within the first 6 hours after symptom onset, but important to recognize. The CT reading panel of ECASS wants to share its experience by publishing this series of early CT scans from study patients in order to improve early recognition of ischemic infarction by CT and thus to improve patient care, and to provide material for practice. In this book each CT scan can be read with and without neuroradiological description. Follow-up scans of each case confirm early findings.Table of ContentsHow to Use this Book.- Patient Scans: Patients 1–20.- Detectability, Prevalence, and Significance of Early CT Signs of Hemispheric Infarction.- Hypodensity of Brain Parenchyma.- Focal Brain Swelling.- Hyperdense Middle Cerebral Artery Sign (HMCAS).- Pathophysiology of Early Parenchymal Hypodensity and Ischemic Brain Swelling and Consequences for Therapy.- Performing CT in Acute Ischemic Stroke: Practical Considerations.- How to Estimate the Extent of Early Ischemic Brain Damage.- Conclusions.- References.
£85.49
Springer-Verlag Berlin and Heidelberg GmbH & Co. KG Leben nach dem Herzeingriff
Book SynopsisNach einem Herzeingriff - einer Operation oder dem Aufdehnen der Herzkranzgefäße - stellen sich viele Fragen:- Was liegt meiner Herzerkrankung zugrunde?- Wie kann ich behandelt werden? Welche Komplikationen kann es geben?- Wie verhalte ich mich in der ersten Zeit nach der Operation?- Wie gestalte ich meinen Alltag nach der Operation? Was darf ich, wo muss ich vorsichtig sein?- Wie lebe ich, um meine Gesundheit zu erhalten?Zuverlässige und detaillierte Antworten geben Ihnen drei erfahrene Herzchirurgen des Herzzentrums Lahr in diesem Buch.Table of ContentsBiologie des Herzens.- Die koronare Herzerkrankung und ihre Behandlung.- Herzklappenerkrankungen und Herzklappenoperationen.- Aortenerkrankungen und Aortenoperationen.- Welche Komplikationen gibt es nach dem Herzeingriff?- Empfehlungen für die Patientinnen und Patienten zum Verhalten nach einem Herzeingriff.- Wichtige Fragen nach dem Herzeingriff.- Gesundes Leben nach dem Herzeingriff.- Herzschrittmacher und Defibrillatoren.- Glossar.
£23.74
Steinkopff Darmstadt Pädiatrische Kardiologie: Erkrankungen des Herzens bei Neugeborenen, Säuglingen, Kindern und Heranwachsenden
Book SynopsisUmfassendes Lehr- und Nachschlagewerk zur schnellen Orientierung in der modernen Diagnostik und Therapie.Table of Contents1 Einführung.- 2 Untersuchungsmethoden.- 3 Pathophysiologische Grundlagen.- 4 Anomalien des linken Ventrikels und der Aorta.- 5 Anomalien des rechten Ventrikels und der Arteria pulmonalis.- 6 Angeborene Anomalien der Lungengefäße.- 7 Angeborene Herzfehler mit überwiegendem Links-rechts-Shunt.- 8 (Komplexe) Angeborene Herzfehler mit überwiegendem Rechts-Iinks-Shunt.- 9 Lageanomalien des Herzens (H. Barth).- 10 Anomalien der Koronararterien.- 11 Seltenere angeborene und erworbene Anomalien des Herzens.- 12 Systemerkrankungen mit Herzbeteiligung.- 13 Entzündliche Erkrankungen des Herzens, erworbene Herzfehler.- 14 Herzrhythmusstörungen.- 15 Der plötzliche Säuglingstod.- 16 Spezielle kinderkardiologische Probleme.- 17 Therapie.- 18 Spezielle Probleme herzkranker Patienten.- Kinderkardiologie in Maß und Zahl (A.A. Schmaltz).- Weiterführende Literatur.
£104.49
Springer-Verlag Berlin and Heidelberg GmbH & Co. KG Langzeit-Elektrokardiographie: Langzeit-Blutdruckmessung Belastungs-Elektrokardiographie
Book SynopsisEntscheidend für eine kompetente Diagnostik mit der Methode der Langzeit-Elektrokardiographie ist fundiertes Wissen über ihre Voraussetzungen, ihre Grenzen und Fehlerquellen sowie über die richtige Bewertung gefundener Rhythmusstörungen.Diese Kenntnisse stellt Ihnen das erfolgreiche Praxisbuch übersichtlich zur Verfügung:* Alle Möglichkeiten von Langzeit-EKG und Langzeit-Blutdruckmessung* Methodik und Klinik* Therapeutische Konzepte und TherapiekontrolleDie Darstellung ist durchgehend am klinischen Problem orientiert und enthält zahlreiche Beispiele, Tabellen, Graphiken und Literaturhinweise.Trade Review"...Die systematische Erarbeitung des Buches ist jedem zu empfehlen, der die Methode einsetzen will. Aber auch der bereits mit ihr Vertraute findet beim Nachschlagen immer wieder Hinweise, die ihm helfen können, auffällige Einzelbefunde richtig einzuordnen." (Anaesthesiologie und Reanimation)Table of Contents1 Historischer Abriß1.- 2 Methodischer Teil.- 2.1 Apparatives Grundkonzept1.- 2.2 Verschiedene Gerätekonzepte1.- 2.2.1 Das Holter-EKG.- 2.2.2 Vollausschrieb des Langzeit-EKG.- 2.2.3 Computerisierte Langzeit-Elektrokardiographie.- 2.2.4 Diskontinuierliche Langzeit-Elektrokardiographie.- 2.3 Anlegen und EKG-Speichern2.- 2.3.1 Anlegen des Langzeit-EKG-Recorders.- 2.3.2 EKG-Speichern.- 2.4 Registrierdauer2.- 2.5 Auswertung2.- 2.5.1 Grundrhythmus und Herzfrequenz.- 2.5.2 Tachykarde Rhythmusstörungen.- 2.5.3 Bradykarde Rhythmus- und Leitungsstörungen.- 2.5.4 Schrittmacherfehlfunktionen1.- 2.5.5 ST-T-Abschnitt2.- 2.5.6 Zuverlässigkeit audiovisueller Auswertung1.- 2.5.7 Zuverlässigkeit computerisierter Auswertung1.- 2.6 Artefaktabgrenzung1.- 2.7 Stellenwert des Belastungs-EKG2.- 2.7.1 Grundlagen und Methodik.- 2.7.2 Bedeutung des Belastungs-EKG für die Arrhythmiediagnostik.- 2.7.3 Vergleich von Belastungs- und Langzeit-EKG in der Arrhythmiediagnostik.- 2.7.4 Vergleich von Belastungs- und Langzeit-EKG in der ST-Strecken-Analyse.- 2.8 Methodische Aspekte der 24-Stunden Blutdruckmessung3.- 3 Klinischer Teil.- 3.1 Häufigkeit und Prognose der Rhythmusstörungen1 bei verschiedenen Personengruppen.- 3.1.1 Gesunde.- 3.1.2 Koronarkranke.- 3.1.3 Patienten mit erworbenen bzw. kongenitalen Herzfehlern3.- 3.1.4 Mitralklappenprolapsträger2.- 3.1.5 Patienten mit Kardiomyopathien2.- 3.1.6 Patienten mit verlängerter QT-Zeit2.- 3.1.7 Patienten mit Synkopen1.- 3.1.8 Patienten mit zerebralen Blutungen1.- 3.2 Rhythmusstörungen vor und zum Zeitpunkt des plötzlichen Herztodes3.- 3.2.1 Patienten.- 3.2.2 Langzeit-EKG-Befunde.- 3.3 Häufigkeit von ST-Streckenveränderungen1.- 3.3.1 Gesunde.- 3.3.2 Koronarkranke.- 3.4 Häufigkeit transitorischer Schrittmacherfehlfunktionen1.- 3.4.1 Schrittmacherindikation und Langzeit-EKG.- 3.4.2 Symptome nach Schrittmacherimplantation.- 3.4.3 Häufigkeit transitorischer Schrittmacherfehlfunktionen.- 3.4.4 Unangemessene Schrittmacherhemmung.- 3.4.5 Sensingdefekt.- 3.4.6 Exit-Block.- 3.4.7 Fehler bei frequenzadaptiver Stimulation.- 3.4.8 Schlußfolgerungen.- 3.5 Klinische Bedeutung der 24-Stunden-Langzeit-Blutdruckmessung3.- 3.5.1 Zirkadiane Rhythmik.- 3.5.2 Normalwerte.- 3.5.3 Praxishypertonie und Praxisnormotonie.- 3.5.4 Fehlender nächtlicher Blutdruckabfall bei sekundärer Hypertonie.- 3.5.5 Antihypertensive Therapie.- 3.5.6 Prognostische Bedeutung der Langzeitblutdruckmessung.- 4 Therapiekontrolle.- 4.1 Spontanvariabilität2.- 4.1.1 Herzfrequenz.- 4.1.2 Rhythmusstörungen.- 4.1.3 ST-Streckenveränderungen.- 4.2 Arrhythmieklassifikation1.- 4.2.1 Hämodynamische Konsequenzen tachykarder Rhythmusstörungen.- 4.2.2 Prognostische Bedeutung tachykarder Rhythmusstörungen.- 4.2.3 Effizienz antiarrhythmischer Behandlung.- 4.3 Kriterien therapeutischer Interventionen2.- 4.4 Langzeit-EKG oder programmierte Stimulation als Therapiekontrolle?2.- 4.4.1 Antiarrhythmische Therapiekontrolle bei asymptomatischen Patienten.- 4.4.2 Antiarrhythmische Therapiekontrolle bei symptomatischen Patienten.- 4.4.3 Vergleich des Langzeit-EKG mit der programmierten Stimulation.- 5 Indikationen zum Langzeit-EKG1.- 5.1 Aussagen der Methoden.- 5.2 Klinische Indikationen.
£66.49
Springer-Verlag GmbH Vorhersage der Schrittmacherwahrscheinlichkeit durch TAVICT basierte Prädikatoren
£59.49
Springer Verlag Advances in Cardiomyopathies: Proceedings of the II Florence Meeting on Advances on Cardiomyopathies April 24–26, 1997
Book SynopsisThe Italian Study Group on Cardiomyopathies organized in Florence in April 1997, eight years after the first successful meeting, the second international symposium devoted to "Advances in Cardiomyopathies". In these years exceptional progress has been made in the field of heart muscle diseases, in clinical research as well as in molecular biology, molec- ular genetics., pathophysiology and treatment. Many of these advances were presented and discussed in Florence by a distinguished team of international experts. Hypertrophic cardiomyopathy was addressed in ten papers; in the first one Seidman reported the results obtained by the use of molecular genetic tech- niques which showed that hypertrophic cardiomyopathy is a heterogeneous disorder caused by different mutations of different genes and discussed the clinical role and significance of genetic testing. Original data regarding the natural history and prognosis of symptomatic patients were obtained in the Italian multicentric study (Cecchi, Lazzeroni), while Baroldi discussed the clinico-pathologic spectrum of the disease in severely symptomatic patients treated with heart transplantation. Sudden death in the young (Basso), the identification and management of high risk patients (Elliott), the clinical importance and the problems of detec- tion of ischemia (Camici) were deeply discussed as well as the indications and results of different types of treatment: medical, surgical, DDD pacing (Spirito, Betocchi, Schoendube).Table of ContentsIntroduction: II Florence Meeting on Advances in Cardiomyopathies The Clinical Significance of Genetic Testing in Familial Hypertrophic Cardiomyopathy The Italian Multicentric Study on Hypertrophic Cardiomyopathy: I.Natural History and Clinical Course of Unselected Patients Detection and Clinical Consequences of Myocardial Ischemia and, Reduced Coronary Reserve The Coronary Circulation is Dysfunctional in both Hypertrophied and Non-Hypertrophied Myocardium Hypertrophic Cardiomyopathy and Sudden Death in the Young: a Pathologist's View Identification and Management of High Risk Patients with Hypertrophic Cardiomyopathy The Italian Multicentric Study on Hypertrophic Cardiomyopathy: II. Prognostic Assessment in Symptomatic Patients Medical Treatment of Heart Failure in Hypertrophic Cardiomyopathy DDD Pacing in HCM: State of the Art Indications and Outcome of Cardiac Surgery for Severely Symptomatic Patients with Hypertrophic Obstructive Cardiomyopathy Genetic Basis of Dilated Cardiomyopathy Virus Infection in Cardiomyopathies: Brief Overview, Recent Advances Organ-specific Cardiac Autoantibodies in Dilated Cardiomyopathy: Pathogenetic Implications Inflammatory Cardiomyopathy: Diagnosis and Therapeutical Options Pathophysiologic Role of Coronary Microcirculatory Impairment in Dilated Cardiomyopathy Molecular Biology of Cardiac Failure Dilated Cardiomyopathy: does Etiological Heterogeneity Portend Clinical Heterogeneity? The Natural History of Dilated Cardiomyopathy. The SPIC Registry 1986-1995. Therapeutic Strategies in Dilated Cardiomyopathy: Immunosuppressive Treatment for Inflammatory Dilated Cardiomyopathy (Myocarditis) Prevention of Sudden Death in Patients with Dilated Cardiomyopathy End-Stage Heart Failure and Timing of Heart Transplantation Beta-Blockers for Heart Failure: Practical Issues DDD Pacing in Dilated Cardiomyopathy Cardiomyoplasty: Surgical Therapy for Ischemic and Idiopathic Dilated Cardiomyopathies .
£42.74
Springer Nuclear Cardiology in Everyday Practice
Book SynopsisThe most salient feature of the infor last four chapters of the book evaluate the mation provided by nuclear medicine is its information from an analytical and pathophysiological and functional charac statistical point of view. This approach is ter. For adequate experimental or clinical required for correct decision-making. interpretation, such information should This book is therefore the result of necessarily be interpreted alongside the accumulated experience in nuclear cardiology views of the clinical cardiologist, who is with the invaluable cooperation of medical able to apply it to the individual patient. statisticians. It is directed to physicians This approach, which is routine in every with an interest in nuclear cardiology, to day clinical practice, reaches its plenitude nuclear medicine specialists wishing to when the whole process is completed and learn the uses and limitations of these an intimate cooperation is established procedures in everyday clinical cardiology, between the nuclear medicine specialist and to cardiologists who feel the need to and the clinical cardiologist. In such understand the rationale and methodology instances, each one of these professionals of the studies which benefit their patients. understands the needs, limits and possi We understand that the ultimate reason bilities of the other. for any scientific book is the transmission The present book is the fruit of such of knowledge, and we are fully conscious cooperation. In our hospital, an efficient of the enthusiasm of the authors of the nuclear cardiology team has been made up present text to achieve that aim.Trade Review... about the Spanish edition ... ` I can unreservedly recommend this book to doctors, radiologists and cardiologists working in nuclear medicine and imaging with radionuclides. It is a most useful source of reference ... it will be extremely well received. ' P.J. Ell in European Jrnl of Nuclear Medicine, 19 Table of ContentsForeword; F.M. Domènech-Torné, J. Soler-Soler. Preface; P. Ell. Introduction; J. Candell-Riera, D. Ortega-Alcalde. 1. Physicochemical and technical fundamentals; P. Galofré-Mora. 2. Image processing; D. Ortega-Alcalde. 3. Stress testing; J. Candell-Riera. 4. Myocardial perfusion studies; D. Ortega-Alcalde. 5. Methods for quantifying myocardial perfusion; J. Castell-Conesa. 6. Studies of myocardial damage and viability; M. Fraile. 7. First-pass radionuclide ventriculography; S. Aguadé-Bruix. 8. Gated blood-pool radionuclide ventriculography; D. Ortega-Alcalde. 9. Ventricular volume measurement; J. Castell-Conesa. 10. Parametric images and Fourier's analysis; D. Ortega-Alcalde. 11. Diagnosis of coronary artery disease; J. Candell-Riera. 12. Prognostic evaluation and follow-up of chronic coronary artery disease; J. Candell-Riera. 13. Diagnosis of acute myocardial infarction; J. Cortadellas-Angel. 14. Prognostic evaluation after acute myocardial infarction; A. Rius-Daví. 15. Congenital heart disease; E. Galve. 16. Valvular heart disease; M.P. Tornos-Mas. 17. Cardiomyopathies; J. Candell-Riera. 18. Methods for diagnostic evaluation; J. Rosselló-Urgell. 19. The probability of a correct diagnosis; M. Olona-Cabases. 20. Uses of multiple logistic regression; J. Vagué-Rafart. 21. Cost analysis and decision trees; B.Bermejo-Fraile. Index.
£161.99
Springer Eicosanoids in the Cardiovascular and Renal Systems
Book SynopsisThe original series, Advances in Prostaglandin Research, edited by Sultan M. M. Karim, was published by MTP Press in three volumes in 1975 and 1976. A glance at those books illustrates the progress that has been made since then. The thromboxanes were mentioned twice (first publication 1975) and prostacyclin not once (first publication 1976); leukotrienes were only on the horizon. The amazing generation of research data in the last 10-15 years has given new, broad insights into many areas, including asthma, inflammation, renaL cardiovascular and gastrointestinal diseases and in reproduction, and has led in some instances to real clinical benefit. This series, Advances in Eicosanoid Research, reflects the current understanding of prostaglandins, thromboxanes and leukotrienes. The aim is to provide an introductory background to each topic and the most up-to-date information available. Although each book stands alone, the eicosanoids cut across many boundaries in their basic actions; selected chapters from each book in the series will provide illuminating and productive information for all readers which will advance their education and research. In the production of this series, I must acknowledge with pleasure my collaboration with editors and authors and the patient endeavours of Dr Michael Brewis and the staff at MTP Press.Trade Review`... adds considerably to the attractiveness of this volume. This volume can be recommended as a good reference book for medical students and graduates of medical school.' Eicosanoids, 2/63-64, 1989 Table of Contents1 Arachidonic acid metabolism and platelet function.- 2 Renal arachidonic acid metabolism.- 3 Arachidonic acid metabolism in renal disease.- 4 Eicosanoids and pulmonary injury.- 5 Eicosanoids in sepsis and its sequelae.- 6 Eicosanoids in myocardial ischaemia and injury.- 7 Prostanoids in clinical and experimental hypertension.- 8 Prostacyclin receptors.- 9 Platelet and vascular smooth muscle thromboxane A2/prostaglandin H2 receptors.- 10 Mechanisms of action of prostaglandin E2 and prostaglandin F2?: PGE and PGF? receptors.
£44.99
Pan Stanford Publishing Pte Ltd Atherosclerosis: Treatment and Prevention
Book SynopsisIn recent years, the understanding of the pathophysiological processes of atherosclerosis, a chronic inflammatory disease of the vessel wall being the leading cause for mortality in industrial countries, has tremendously increased. The feasibility of translating such knowledge to novel therapeutic approaches is currently being explored at various levels. This book highlights advances in atherosclerosis and links these to relevant therapeutic strategies. It compiles and details cutting-edge research in cardiovascular medicine from internationally renowned authors. Table of ContentsNovel approaches in treatment of atherosclerosis. Chemokines as therapeutic targets of atherosclerosis. MIF antagonism as a therapeutic approach to atherosclerosis. Peptide-based vaccination strategies to promote Treg- or antibody-mediated atheroprotection. Modulation of prostanoids in the treatment of atherosclerosis. Stabilization of mast cells for taming vulnerable plaques. HDL, ABC transporters, and cholesterol efflux as therapeutic targets in atherosclerosis. Role of selective phospholipase A2 inhibition in the treatment of atherosclerosis. Modulation of the rennin-angiotensin system in atherosclerosis. Role of matrix metalloproteases as targets for the prevention of atherosclerosis. Probucol-derivates in the treatment of atherosclerosis. Interference with apoptosis and ER stress in the treatment of atherosclerosis. MicroRNAs in the pathogenesis and therapy of atherosclerotic vascular disease. Neutrophils and their granule proteins in the treatment of atherosclerosis. Platelets in the treatment of atherosclerosis. Costimulatory molecules in the treatment of atherosclerosis.
£133.00
University of Notre Dame Press On Having a Heart Attack
Book SynopsisNotre Dame English professor emeritus William O'Rourke recounts his heart attack and the experiences he had during recuperation. From the resulting heightened awareness of his mortality, O'Rourke asks us to change behaviors and to pay attention to our health.Trade Review"O'Rourke' s book and its long description of having a heart attack may scare the bejesus out of you, but it certainly sheds a lot of light on the subject. He's writing about what he knows and he knows a lot. His book is full of life—full of heart—and necessary reading for anyone who's ever thought twice about the tough organ that keeps us alive." —Malachy McCourt, author of A Monk Swimming and Bush Lies in State"The story of William O'Rourks's heart attack is as compelling as a thriller because it is a thriller. As always, O'Rourke's prose is crisp, witty, and wholly original. The chronicle of his recovery demystifies a frightening illness, leaving a reader enlightened and, unexpectedly, cheered." —Valerie Sayers, author of Brian Fever and Due East"In the first few pages of William O'Rourke's gripping book I learned what it feels like to have a heart attack and how the press or pleasure of daily events can keep us postponing the visit to the Emergency Room. Now, I tell myself, I'll be prepared even in the middle of the night or at a sports event. Thanks to my husband's many years of MS, I did have an idea of how important a good doctor, a ready wife or husband, an eagle eye for proceedings, and even chance can be in determining one's future—but the uninitiated in such mysteries will find On Having A Heart Attack to be full of first person insights. Besides, if it has already happened to O'Rourke, maybe it won't happen to his readers!" —Maggie Strong, author of Mainstay: For the Well Spouse of the Chronically Ill"Despite its somber subject, the book is as gripping as fiction, full of drama, conflict, and angst. . . . While convalescing, O'Rourke read all he could find in the literature of MI (myocardial infarction) but met with a singular lack of comprehensive accounts of the physical and psychic experience itself, and how it affects the family and friends of the patient. This he supplies with wry wit and unsparing rue, distillations of the novelist's second nature-attentiveness in calamity, and richness of recall." —Provincetown Arts"For anyone who has ever had a serious medical crisis, or been close to someone who has, William O'Rourke's book is essential reading. O'Rourke takes us on a fascinating, compelling journey into the literal and figurative heart of a gloriously full and fragile life. He illuminates much about our vitality and our mortality, and the ways in which fortune and modern medicine can collaborate in our individual and collective fates. This is a rich tale by a splendid storyteller—a most unforgettable, informative, and deeply moving memoir of one man's struggles and triumphs." —Jay Neugeboren, author of Open Heart: A Patient's Story of Life-Saving Medicine and Life-Giving Friendship"A must-read for practicing physicians, cardiologists, nurses, physician assistants, and the general public. . . . [T]his is an excellent, thoroughly informed book. It will be helpful for recuperating patients and their families and for anyone concerned about heart disease." —Journal of the American Medical Association“This very personal account of exactly what it was like to have a heart attack, to notice medical personnel somewhat hesitant to treat him until they saw his insurance card, to contemplate the possibility of dying before his son turned two, and to make lifestyle changes to lower the risk of a second attack is frightening, moving and sometimes funny.” —Booklist“Books about heart attacks and heart disease abound, mostly authored by health care professionals who specialize in the treatment of heart patients or work as nutritionists. Books written by actual survivors of an MI . . . are rare and a book, such as this, written by someone who is both a survivor and a noted author, is certainly the exception . . . this memoir is much more than just a self-help book. The author examines the many personal thoughts the patient stricken by a heart attack unavoidably encounters. . . . It is a book that doctors and nurses should read and learn from, and one that all those should read who are potentially threatened with heart disease.” —Third Coast
£18.04
Yale University Press The Heart
Book SynopsisProvides an illustrated account of changes in our perception of what the heart does and what it means. This book explores the symbolic significance of the heart in ancient Egypt, China, India and Greece, its role in Aztec ceremony and its place in the medieval world. It considers the centrality of the heart in Christianity and other religions.Table of ContentsLouisa Young: The Human Heart; Francis Wells: The Renaissance Heart; Emily Jo Sargent: The Sacred Heart; Fay Bound Alberti: The Emotional Heart; Ayesha Nathoo: The Transplanted Heart; Melissa Larner: The Healing Heart; Ted Bianco: The Animal Heart; Michael Bracewell: The Broken Heart; Jon Turney: The Future Heart.
£16.99
Springer-Verlag New York Inc. ECG Holter Guide to Electrocardiographic
Book SynopsisTechnical Aspects.- Electrocardiographic Interpretation.- Presenting ECG Holter Data.- Clinical Applications.- Other ECG Recording Systems.- ECG Holter and Implanted Cardioverter Defibrillators.- ECG Report Example.- Conclusion.Table of ContentsTechnical Aspects.- Electrocardiographic Interpretation.- Presenting ECG Holter Data.- Clinical Applications.- Other ECG Recording Systems.- ECG Holter and Implanted Cardioverter Defibrillators.- ECG Report Example.- Conclusion.
£52.24
John Wiley & Sons Inc Central Venous Catheters
Book SynopsisThe author addresses the different stages a patient may experience prior to receiving a VAD (Ventricular Assist Device, beginning with the various reasons for gaining venous access and specific challenges this may present e.g. age, acute and chronic disease processes, anatomical anomalies and cosmetic issues.Table of ContentsChapter 1: The History of Central Venous Access. Chapter 2: Applied anatomy of the central veins. Chapter 3: Patient Examination and assessment: choice of devices. Chapter 4: Catheter design and materials. Chapter 5: Cannulation of the Jugular Veins. Chapter 6: Practical Venous Access via the Femoral Vein. Chapter 7: Central venous access via the subclavian and axillary veins. Chapter 8: Peripherally Inserted Central Catheters. Chapter 9: Ultrasound Guided Venous Access. Chapter 10: The role of diagnostic and interventional radiology in the placement and management of central venous catheters. Chapter 11: Problems and Practical Solutions during Insertion of Catheters. Chapter 12: Complications of central venous access. Chapter 13: The Pathogenisis and Prevention of Intravascular Catheter Related Infections. Chapter 14: Aftercare and Management of Central Venous Access Devices. Chapter 15: Removal of central venous access devices. References. Index.
£44.60
John Wiley and Sons Ltd Comparative Cardiac Imaging
Book SynopsisTable of ContentsNotes on Contributors, xi Foreword, xv Preface, xvii Abbreviations, xix About the Companion Website, xxi Part I Congenital Heart Disease in the Adult Case 1 Aneurysmal Aorto–Left Ventricular Tunnel and Bicuspid Aortic Valve with Severe Stenosis, 3Fanxia Meng, Bo Zhang, Nan Xu, and Jing Ping Sun Case 2 Anomalous Origin of the Left Coronary Artery from the Pulmonary Trunk, 9Weihua Wu and Jing Ping Sun Case 3 Anomalous Origin of Right Coronary Artery, 15Kevin Ka]Ho Kam, Jing Ping Sun, and Xing Sheng Yang Case 4 Interrupted Aortic Arch associated with Aortopulmonary Window, 19Yali Xu and Jing Ping Sun Case 5 Congenitally Corrected Transposition of the Great Arteries, 23Ming-Ming Sim and Jing Ping Sun Case 6 Coronary Fistula, 29Fanxia Meng, Jing Ping Sun, Ming Chen, and Lei Zhang Case 7 Crista Terminalis Bridge Mimicking Right Atrial Mass, 35Jing Ping Sun, Alex Pui]Wai Lee, and Xing Sheng Yang Case 8 A Criss]cross Heart with Double Outlet Right Ventricle, 39Lianghua Xia, Bo Zhang, Fanxia Meng, and Jing Ping Sun Case 9 Double]Chambered Right Ventricle with Ventricular Septal Defect, 45Lei Zhang, Fanxia Meng, Ming Chen, and Jing Ping Sun Case 10 Isolated Double]Orifice Mitral Valve, 51Jing Ping Sun Case 11 The Gerbode Defect: A Ventriculo]Atrial Defect, 55Xing Sheng Yang and Jing Ping Sun Case 12 Intralobar Pulmonary Sequestration, 61Lei Zhang and Jing Ping Sun Case 13 Partial Anomalous Pulmonary Venous Connection with Secundum Atrial Septal Defect, 67Liu Chen, Hong Tang, Yuan Feng, and Jing Ping Sun Case 14 Pulmonary Arteriovenous Malformation, 73Jing Ping Sun, Xing Sheng Yang, and Ka]Tak Wong Case 15 Right Pulmonary Agenesis associated with Congenital Heart Diseases, 79Junli Hu, Guiling Sui, and Jing Ping Sun Case 16 Compressive Giant Right Atrial Diverticulum, 83Guozhen Yuan, Shaochun Wang, Bryan P. Yan, and Jing Ping Sun Case 17 Shone’s Syndrome, 87Weihua Wu, Bryan P. Yan, and Jing Ping Sun Case 18 Subaortic Membrane in the Adult, 95Jing Ping Sun and Alex Pui]Wai Lee Case 19 Supracardiac Total Anomalous Pulmonary Venous Connection, 101Fanxia Meng, Ming Chen, and Jing Ping Sun Case 20 Tricuspid Atresia, 107Jing Ping Sun Case 21 Isolated Congenital Tricuspid Valve Dysplasia in a 38]year]old Adult, 111Ligang Fang and Jing Ping Sun Case 22 Unroofed Coronary Sinus Defect, 115Ran Guo, Jing Ping Sun, and Alex Pui]Wai Lee Part II Artery Disease Case 23 Acute Aortic Regurgitation caused by Spontaneous Aortic Valve Rupture, 123Li]Tan Yang, Ping]Yen Liu, Cheng]Han Lee, and Wei]Chuan Tsai Case 24 Bicuspid Aortic Valve Complicated by Pseudo]aneurysm of Aortic Root Abscesses, 129Shuran Huang, Zhanguo Sun, and Jing Ping Sun Case 25 Coronary Artery Vasculitis in Patient with Systemic Lupus Erythematosus, 135Ligang Fan, Yining Wang, and Jing Ping Sun Case 26 Aortic Dissection, 141Jing Ping Sun and Xing Sheng Yang Case 27 Large Thrombus in Giant Unruptured Noncoronary Sinus of Valsalva Aneurysm, 149Weihua Wu and Jing Ping Sun Case 28 Isolated Pulmonary Vasculitis, 155Hongmei Xia, Yuanqing Cai, and Jing Ping Sun Case 29 Giant Left Ventricular Pseudoaneurysm, 161Liu Chen, Hong Tang, Yuan Feng, and Jing Ping Sun Case 30 Salmonela Aortitis: A Rare Cause of Fever and Back Pain in the Elderly, 167Jen]Li Looi, Alex Pui]Wai Lee, and Jing Ping Sun Case 31 Subepicardial Aneurysm of Left Ventricle: A Rare Complication of Acute Myocardial Infarction, 173Ying Zheng, Zhiqing Qiao, Xuedong Shen, and Ben He Case 32 Coronary Artery Disease and Systemic Vasculitis, 179Ligang Fang, Jing Ping Sun, and Yining Wang Part III Cardiac Mass Case 33 Primary Cardiac Angiosarcoma in Left Atrium, 187Hongjun Wang, Junli Hu, Shaochun Wang, and Jing Ping Sun Case 34 Atypical Left]Atrial Papillary Fibroelastoma, 193Kevin Ka]Ho Kam, Alex Pui]Wai Lee, and Jing Ping Sun Case 35 Cardiac Lipoma with Ventricular Arrhythmias, 197Litong Qi, Ying Yang, Yong Huo, and Jing Ping Sun Case 36 Primary Cardiac Pheochromocytoma, 201Ligang Fang, Jing Ping Sun, and Yining Wang Case 37 Cardiac Rhabdomyosarcoma of the Left Atrium, 205Lan Ma, Ming Chen, and Jing Ping Sun Case 38 Unusual Cardiac Fibroelastoma, 211Fanxia Meng, Ming Chen, and Jing Ping Sun Case 39 Pulmonary and Cardiac Inflammatory Myofibroblastic Tumor, 217Yong Jiang, Hao Wang, and Jing Ping Sun Case 40 Intravenous Leiomyomatosis with Cardiac Metastases, 221Ligang Fang, Jing Ping Sun, and Yining Wang Case 41 Intramural Left Atrial Hematoma Complicating Catheter Ablation for Atrial Fibrillation, 225Jen]Li Looi, Alex Pui]Wai Lee, and Jing Ping Sun Case 42 Primary Cardiac Lymphoma: Two Rare Cases, 229Yi Liu, Min Xu, Bo Zhang, and Jing Ping Sun Case 43 Mass in Left Atrium and Appendage, 235Jing Ping Sun, Fanxia Meng, Xing Sheng Yang, Alex Pui]Wai Lee, and Bo Zhang Case 44 Metastatic Cardiac Lymphoma, 241Jing Ping Sun, Xing Sheng Yang, and Alex Pui]Wai Lee Case 45 Metastatic Renal Carcinoma in Inferior Vena Cava, 245Jing Ping Sun and Jen]Li Looi Case 46 Pericardial Metastasis Mass from Thyroid Carcinoma, 249Changchun Hao and Jing Ping Sun Case 47 Spindle Cell Sarcoma: A Rare Case of Multicardiac Chamber Mass, 253Chengzheng Zhang, Junli Hu, Shaochun Wang, and Jing Ping Sun Part IV Cardiomyopathy and Myocarditis Case 48 Fulminant Myocarditis, 259Lei Zhang, Jingjin Wang, and Jing Ping Sun Case 49 Cardiac Amyloidosis, 267Jing Ping Sun, Xing Sheng Yang, Bryan P. Yan, and Ka]Tak Wong Case 50 Hypertrophic Cardiomyopathy with Apical Aneurysm, 281Jing Ping Sun, Xing Sheng Yang, and Ka]Tak Wong Case 51 Arrythmogenic Right Ventricular Dysplasia, 287Doris T. Chan, Anna K. Y. Chan, and Jing Ping Sun Case 52 Danon Disease, 293Ligang Fang and Jing Ping Sun Case 53 Acute Eosinophilic Myocarditis, 299Xianda Ni and Jing Ping Sun Case 54 Noncompaction Cardiomyopathy with Apical Aneurysm, 305Xianda Ni, Xing Sheng Yang, and Jing Ping Sun Part V Diversification Case 55 A Fistula between Aortic Pseudoaneurysm and Right Atrium, 313Ligang Fang and Jing Ping Sun Case 56 Dual Aortic and Mitral Valve Aneurysms in a Patient with Infective Endocarditis, 317Weihua Wu, Lan Ma, Xing Sheng Yang, Bryan P. Yan, and Jing Ping Sun Case 57 Intracardiac Thrombus in Behcet’s Disease, 321Ligang Fang, Jing Ping Sun, and Yining Wang Case 58 Cardiac Hydatid Disease, 325Ligang Fang, Jing Ping Sun, and Yining Wang Case 59 Diagnosis of Constrictive Pericarditis with Multimodality Imaging, 329Alex Pui]Wai Lee and Jing Ping Sun Case 60 Inverted Left]Atrial Appendage, 333Haiping Zhang and Jing Ping Sun Case 61 Inferior Vena Stent Fracture and Multiple Heart Injuries caused by Migration, 337Ligang Fang, Yining Wang, and Jing Ping Sun Case 62 Anterior Mitral Valve Aneurysm: A Rare Complication of Aortic Valve Endocarditis, 341Jinchuan Yan, Fen Zhang, Yi Liang, and Jing Ping Sun Index, 345
£77.36
John Wiley and Sons Ltd Quality in Laboratory Hemostasis and Thrombosis
Book SynopsisQuality in Laboratory Hemostasis and Thrombosis Second Edition Edited by Steve Kitchen, Clinical Scientist, Sheffield Haemophilia and Thrombosis Centre, Royal Hallamshire Hospital and Scientific Director, UK National External Quality Assessment Scheme (FQAS) for Blood Coagulation, Scientific Director, WHO and WFH International External Quality Assessment Programs for Blood Coagulation, Sheffield, UK John D Olson, Professor and Vice Chair for Clinical Affairs, Department of Pathology, University of Texas Health Sciences Centre, San Antonio, Texas, USA F. Eric Preston, Emeritus Professsor of Haematology, University of Sheffield and Director, WHO and WFH International External Quality Assessment Programs for Blood Coagulations, Sheffield, UK The hemostasis laboratory has a vital role in the diagnosis and management of patients with familial and acquired hemorrhagic and thrombotic disorders. Rapid changes in the numbeTable of ContentsContributors, vii Foreword, x Preface, xii Steve Kitchen, John D. Olson, & F. Eric Preston Part 1: General Quality Program 1 General quality planning in the hemostasis laboratory, 3 John D. Olson 2 Hemostasis test validation, performance, and reference intervals: international recommendations and guidelines, 12 Richard A. Marlar 3 Causes of errors in medical laboratories, 22 Giuseppe Lippi & Emmanuel J. Favaloro 4 International standards in hemostasis, 32 Trevor W. Barrowcliffe & Anthony R. Hubbard 5 Sample integrity and preanalytical variables, 45 Dorothy (Adcock) Funk 6 Internal quality control in the hemostasis laboratory, 57 Steve Kitchen, F. Eric Preston, & John D. Olson 7 External quality assessment in hemostasis: its importance and significance, 65 F. Eric Preston, Steve Kitchen, & Alok Srivastava 8 The unique challenges of hemostatic testing in children, 77 M. Patricia Massicotte, Mary E. Bauman, Vanessa Chan, & Anthony K.C. Chan Part 2: Quality in Coagulation Testing 9 Initial evaluation of hemostasis: reagent and method selection, 95 Wayne L. Chandler 10 Assay of factor VIII and other clotting factors, 105 Steve Kitchen & F. Eric Preston 11 Application of molecular genetics to the investigation of inherited bleeding disorders, 115 Stefan Lethagen, Morten Dunø, & Lars Bo Nielsen 12 Detecting and quantifying acquired functional inhibitors in hemostasis, 124 Bert Verbruggen, Myriam Dardikh, & Britta Laros-van Gorkom 13 Standardization of d-dimer testing, 136 Guido Reber & Philippe de Moerloose 14 Point-of-care testing in hemostasis, 147 Chris Gardiner, Dianne Kitchen, Samuel Machin, & Ian Mackie Part 3: Quality in Testing for Platelet Function and von Willebrand Disease 15 Diagnostic assessment of platelet function, 159 Paquita Nurden, Alan Nurden, & Martine Jandrot-Perrus 16 Laboratory evaluation of heparin-induced thrombocytopenia, 174 Theodore (Ted) E. Warkentin & Jane C. Moore 17 Laboratory evaluation of von Willebrand disease: phenotypic analysis, 192 Emmanuel J. Favaloro 18 Laboratory analysis of von Willebrand disease: molecular analysis, 204 Anne C. Goodeve & Ian R. Peake Part 4: Quality in Thrombophilia Testing and Monitoring Anticoagulation 19 Quality issues in heritable thrombophilia testing, 219 Isobel D. Walker & Ian Jennings 20 Evaluation of antiphospholipid antibodies, 233 Michael Greaves 21 Monitoring heparin therapy, 244 Marilyn Johnston 22 Monitoring oral anticoagulant therapy with vitamin K antagonists, 253 Armando Tripodi 23 Monitoring new anticoagulants, 264 Elaine Gray & Trevor W. Barrowcliffe Index, 273
£87.26
John Wiley and Sons Ltd Cardiovascular Disease and Health in the Older
Book SynopsisWritten by leading experts in the field, Cardiovascular Diseases and Health in the Older Patient covers the epidemiology, pathophysiology and management of cardiovascular disease in the older patient.Trade Review“Because it specifically addresses cardiovascular disease in the elderly this is a useful addition to the literature.” (Doody's, 9 August 2013)Table of ContentsList of Contributors, vii Foreword, ix Introduction, xi 1 Epidemiology of Heart Disease, 1 Ahmed H. Abdelhafiz 2 Cardiac Ageing and Systemic Disorders, 29 David J. Stott and Terence J. Quinn 3 Hypertension, 44 Anthony S. Wierzbicki and Adie Viljoen 4 Lipid Management, 68 Adie Viljoen and Anthony S. Wierzbicki 5 Arrhythmias, 90 Abhay Bajpai and A. John Camm 6 Hypotension, 135 Suraj Alakkassery 7 Ischaemic Heart Disease, 152 Wilbert S. Aronow 8 Heart Failure, 172 Michael W. Rich 9 Cardiac Surgery, 202 Ulrich O. von Oppell and Adam Szafranek 10 Cardiac Rehabilitation, 234 Niccol`o Marchionni, Francesco Fattirolli, Francesco Orso, Marco Baccini, Lucio A. Rinaldi and Giulio Masotti 11 Acute Stroke Care and Management of Carotid Artery Stenosis, 261 David Doig and Martin M. Brown 12 Stroke Rehabilitation, 299 Lalit Kalra 13 Communication Disorders and Dysphagia, 329 Pamela M. Enderby 14 Peripheral Arterial Disease, 345 Leocadio Rodr´ýguez-Ma ˜ nas, Marta Castro Rodr´ýguez and Cristina Alonso Bouz´on 15 Venous Thromboembolism, 366 Gordon D.O. Lowe 16 Planning Cardiovascular Investigations and Management of Older People, 376 Jennifer K. Harrison, Terence J. Quinn and David J. Stott Index, 395
£87.26
University of California Press The Heart
Book SynopsisThis title is part of UC Press's Voices Revived program, which commemorates University of California Press's mission to seek out and cultivate the brightest minds and give them voice, reach, and impact. Drawing on a backlist dating to 1893, Voices Revived makes high-quality, peer-reviewed scholarship accessible once again using print-on-demand technology. This title was originally published in 1966.
£35.70
Harvard University Press Eugene Braunwald and the Rise of Modern Medicine
a huge range and FREE tracked UK delivery on ALL orders.
£32.36
John Wiley & Sons Inc 100 Questions in Cardiology
Book SynopsisWhat drugs should be used to maintain someone in sinus rhythm who has paroxysmalatrial Fibrillation? How do I investigate the relatives of a patient with sudden cardiac death? Which cardiac patients should never get pregnant? This book answers these and other questions.Table of ContentsContributors. Introduction. 1. What are the cardiovascular risks of hypertension?. 2. Is 24 hour blood pressure monitoring necessary, and what do I do with the information?. 3. Who should be screened for a cause of secondary hypertension? How do I screen?. 4. What blood pressure should I treat, and what should I aim for when treating a 45 year old, a 60 year old, a 75 year old or an 85 year old?. 5. Is one treatment for hypertension proven to be better than another in terms of survival?. 6. It was once suggested that calcium channel blockers might be dangerous for treating hypertension. Is this still true?. 7. How can I outline a management plan for the patient with essential hypertension?. 8. How do I manage the patient with malignant hypertension?. 9. Which asymptomatic hypercholeterolaemic patients benefit from lipid-lowering therapy? What cholesterol level should I aim for?. 10.Which patients with coronary disease have been proven to benefit from pharmacological intervention? What lipid levels should I aim for?. 11.What drugs should I choose to treat dyslipidaemia, and how should I monitor treatment?. 12. What are the side effects of lipid-lowering therapy, and how should they be monitored?. 13. Is there a role for prescribing antioxidant vitamins to patients with coronary artery disease? If so, who should get them, and at what dose?. 14. What is the sensitivity, specificity and positive predictive value of an abnormal exercise test?. 15. What are the risks of exercise testing? What are the contraindications?. 16. What are the stratification data for risk from exercise tests in patients with angina? Which patterns of response warrant referral for angiography?. 17. Who should have a thallium scan? How does it compare with standard exercise tests in determining risk?. 18. What are hibernating and stunned myocardium? What echocardiographic techniques are useful for detecting them? How do these methods compare with others available?. 19. Which class of antianginal agent should I prescribe in stable angina? Does it matter?. 20. What is the role of troponin T in the diagnosis and risk stratification of acute coronary syndromes?. 21. What is the risks of myocardial infarction and death in someone with unstable angina during hospital admission, at six months and one year?. 22. What medical treatments of unstable angina are of proven benefit?. 23. Under what circumstances should the patient with unstable angina undergo PTCA or CABG?. 24. What new approaches are there to prevent restenosis following PTCA?. 25. Which thrombolytics are currently available for treating acute myocardial infrarction? Who should receive which one? What newer agents are there?. 26. Is angioplasty better than thrombolysis in myocardial infarction? Which patients should receive primary or "hot" angioplasty for these conditions?. 27. Whar are the contraindication to thrombolytic therapy for acute myocardial infarction? Is diabetic retinopathy a contraindication?. 28. Exercise testing after myocardial infarction: how soon, what protocol, how should results be acted upon?. 29. What are the risks of recurrent ischaemic events after myocardial infarction: prehospital, at 30 days and at 1 year?. 30. What is appropriate secondary prevention after acute myocardial infarction?. 31. What advice should I give patients about driving and flying after myocardial infarction?. 32. What is the mortality rate for cardiogenic shock complicating myocardial infarction? How should such patients be managed to improve outcome and what are the results?. 33. What is the risk of a patient dying or having a myocardial infarction around the time of surgery for coronary artery disease and for valve replacements?. 34. Which patients with post-infarct septal rupture should be treated surgically, and what are the success rates?. 35. What patterns of coronary disease are associated with improved short and long term survival after CABG compared with medical therapy?. 36. Coronary artery bypass grafting: what is the case for total arterial revascularization?. 37. How common are neuropsychological complications after cardiopulmonary bypass (CPB)? How predictable are severe are they? Can they be prevented?. 38. Are there benefits to switching from sulphonylureas to insulin after coronary artery bypass grafting?. 39. How does recent myocardial infarction affect the perioperative risks of coronary artery bypass grafting?. 40. How soon before cardiac surgery should aspirin be stopped?. 41. When should we operate to relieve mitral regurgitation?. 42. When to repair the miral valve?. 43. What is the Ross procedure? When is it indicated and what are the advantages?. 44. What is the risk of stroke each year after a) tissue or b) mechanical MVR or AVR? What is the annual risk of bacterial endocarditis on these prosthetic valves?. 45. When and how should a ventricular septal defect be closed in adults?. 46. How should I treat atrial septal defects in adults?. 47. How do I follow up a patient who has had correction of aortic coarctation? What should I look for and how should they be managed?. 48. How should I investigate a patient with hypertrophic cardiomyopathy (HCM)?. 49. What is the medical therapy for patients with hypertrophic cardiomyopathy, and what surgical options are of use?. 50. What is the role of permanent pacing in hypertrophic cardiomyopathy?. 51. How do I investigate protocol should a patient with hypertrophic cardiomyopathy? How should they be followed?. 52. What investigation protocol should a patient with dilated cardiomyopathy undergo?. 53. Which patients with impaired ventricles should receive an ACE inhibitor? We are the survival advantages? Do ATI-receptor antagonist confer the small advantages?. 54. What is the role of vasodilators in the chronic heart failure? Who should receive them?. 55. Should I give digoxin to patients with heart failure if they have sinus rhythm? If so, to whom? Are there dangers to stopping it once started?. 56. Which patient with heart failure should have a beta blocker? How do I start it and how should I monitor therapy?. 57. What is mean and model life expectancy in NYHA I-IV heart failure?. 58. What are LVADs and BIVADS, who should have them?. 59. Who is eligible heart or heart-lunging transplant? How do I assess suitability for transplantation?. 60. What are the survival figures for the heart and heart-lunging transplantation?. 61. What drugs do post-transplant patients require, and what are there side effects? How should I follow up such patients?. 62. Can a cardiac transplant patient get angina? How is this investigated?. 63. What drugs should be used to maintain someone in sinus rhythm who has paroxysmal atrial fibrillation? Is there a role for digoxin?. 64. Which patients with paroxysmal or chronic atrial fibrillation should I treat with aspirin, warfarin or neither?. 65. Which patients with SVT should be referred for an intracardiac electrophysiological study (EP study)? What are the success rates and risks of radiofrequency (RF) ablation?. 66. What drugs should I use for chemically cardioverting atrial fibrillation and when is DC cardioversion preferable?. 67. How long should someone with atrial fibrillation be anticoagulated before DC cadioversion, and how long should this be continued afterwards?. 68. What factors determine the chances of successful elective cardioversion from atrial fibrillation?. 69. What are the risks of elective DC cardioversion from atrial fibrillation?. 70. Are patients with atrial flutter at risk of embolisation when cardioverted? Do they need anticoagulation to cover the procedure?. 71. How do I assess the risk of CVA or TIA in a patient with chronic atrial fibrillation?. 72. How sensitive are transthoracic and transoesophageal echocardiography for the detection of thrombus in the left atrium?. 73. What are the roles of transthoracic and transoesophageal echocardiography in patients with a TIA or stroke?. 74. Which patient with a patent foramen ovale should be referred for closure?. 75. How should I investigate the patient with collapse? Who should have a tilt test, and what do I do if it is positive?. 76. What are the chances of a 24 hour tape detecting the causes for collapse in a patient? What other alternative monitoring devices are now available?. 77. Should the patient with trifascicular disease be routinely paced? If not, why not?. 78. Who should have VVI pacemakers and who should have dual chamber pacemakers? What are the risks of pacemaker insertion?. 79. Can a patient with a pacemaker touch an electric fence? …have an MRI scan? …go through airport metal detectors? …use a mobile phone?. 80. What do I do if a patient has a pacemaker and needs cardioversion?. 81. What do I do about non-sustained ventricular tachycardia on a 24 hour tape?. 82. How do I treat torsades de pointers at a cardiac arrest?. 83. How do I assess the patient with long QT? Should I screen relatives, and how? How do I treat them?. 84. How do I investigate the relatives of a patient with sudden cardiac death?. 85. What percentage of patients will suffer the complications of amiodarone therapy, and how reversible are the eye, lung, and liver changes? How do I assess thyroid function in someone on amiodarone therapy?. 86. Who should have a VT stimulation study? What are the risks and benefits?. 87. What are the indications for implantable cardioverter defibrillator (ICD) implantation and what are the survival benefits?. 88. How do I manage the patient with an ICD?. 89. How do I follow up the patient with the implantable cardioverter defibrillator?. 90. What do I do if an ICD keeps discharging?. 91. How do I manage the pregnant woman with dilated cardiomyopathy?. 92. How do I manage the pregnant woman with valve disease?. 93. Which cardiac patients should never get pregnant? Which cardiac patients should undergo elective Caesarean section?. 94. A patient is on life-long warfarin and wishes to become pregnant. How should she be managed?. 95. How should the anticoagulation of a patient with a mechanical heart valve be managed for elective surgery?. 96. What are the indications for surgical management of endocarditis?. 97. What is the morbidity and mortality of endocarditis with modern day management (and how many relapse)?. 98. What percentage of blood cultures will be positive in endocarditis?. 99. Which patients should receive antibiotic prophylaxis for endocarditis, and which procedures should be covered in this way?. 100. Which patients should undergo preoperative non-invasive investigations or coronary angiography?. 101. Which factors predict cardiac risk from general surgery and what is the magnitude of the risks associated with each factor?. Index.. . .
£44.60
University of Pennsylvania Press Partners of the Heart
Book SynopsisInspiration for the Emmy Award-winning HBO film Something the Lord Made and the award-winning PBS documentary Partners of the Heart.Trade Review"The fascinating tale of an extraordinary black man's involvement, growth, and final recognition in a white man's world of surgical research and medical practice. . . . At the same time, an insightful firsthand account of the genesis of some of the pioneering research into the nature of shock and some of the early procedures in cardiovascular surgery." * Journal of the History of Medicine *"For one who had the privilege of being a student, coworker, and later a colleague of Vivien Thomas, reading this autobiography is an extraordinary experience. Although the reviewer worked with him in the laboratory for 20 years, often on a daily basis, many features of this unique and compelling story have been revealed for the first time." * David C. Sabiston, Journal of the American Medical Association *Table of ContentsForeword by Mark M. Ravitch, M.D. Preface Acknowledgements PART ONE. THE VANDERBILT YEARS PART TWO. THE HOPKINS YEARS PART THREE. RECOGNITION References Name Index Subject Index
£21.59
Rutgers University Press Iatrogenicity Causes and Consequences of
Book SynopsisThis book addresses consequences on the cardiovascular system that arise from iatrogenesis— the occurrence of untoward effects resulting from actions of health care providers, including medical errors, medical malpractice, practicing beyond one’s expertise, adverse effects of medication, unnecessary treatment, inappropriate screenings, and surgical errors.Table of ContentsTABLE OF CONTENTS Part I: MEDICAL HARM 1. The Concept and Spectrum of "Iatrogenicity" I. Gussak and J. Kostis 2. Iatrogenicity: Definition, History and Modern Context M. Gussak, I. Gussak, and J. Kostis 3. Epidemiology and Public Health Aspects and Implications: Regulatory, Legal and Ethical Dimensions of Iatrogenicity S. Jones and M. Gonzalez 4. Risk Management: The Medical Center Administration Perspective S. Jones and M. Gonzalez 5. Iatrogenicity from the Patient's Perspective J. Dobrzynski, S. Jones, and M. Gonzalez 6. A Naturopathic Perspective on Iatrogenesis C. Fleetwood Part II: IATROGENICITY OF CARDIOVASCULAR DURGS AND CARDIOVASCULAR TOXICITY OF NON-CARDIAC DRUGS 7. Clinical Manifestations of Acute and Chronic Drug-Induced Iatrogenic Cardiovascular Diseases and Syndromes I. Gussak, G. Yan, A. Jahangir, and J. Kostis 8. Drug-Induced Cardiac Arrhythmias and Sudden Cardiac Death A. Narichania, Y. Yokoyama, and W.K. Shen 9. Chemotherapy-Induced Cardiomyopathies E. Birati and B. Jessup 10. Iatrogenicity of Blood Pressure Mesaurement in the Diagnosis of Hypertension T. Giles, G. Sander, I. Gussak, and J. Kostis 11. Antihypertensive Drug-Induced Iatrogenic Cardiovascular Syndromes R. Kalaitzidis and G. Bakris 12. Iatrogenicity of Cardiovascular Drugs Associated with Cardiac and Non-Cardiac Toxicities: Antihypertensive Agents and Biologics E. Hermes-Desantis and J. Barone 13. Iatrogenic Aspects of Hypertension in Pregnancy: Focus on Preeclampsia C. Thomopoulos and T. Makris 14. Women and Iatrogenic Cardiovascular Disease: Menopausal Estrogen as the Prime Suspect G. Bachmann, M. Rees, and N. Phillips 15. Iatrogenic Aspects of Lipid-Lowering Agents, Thrombolytic, Antiplatelet, and Antithrombotic Agents C. Tsioufis, D. Konstantinidis, N. Vogiatzakis, and K. Dimitriadis 16. Iatrogenic Effects of ‘Urologic' Drugs on the Cardiovascular System K. Stavropoulos, C. Boutari, K. Imprialos, and M. Doumas 17. Iatrogencity and Antianginal Drugs A. Moreyra and W.J. Kostis 18. Anti-Diabetic Drugs and Cardiovascular Risk: Where Do We Stand? R. Kumar 19. Cardiovascular Iatrogenicity in Older Adults A. Khan, #. Ali, #. Iyengar, #. Hagiwara, #. Periyakoil, #. Patel, #. Malone Part III: IATROGENCITY OF DIAGNOSTIC AND THERAPEUTIC, INVASIVE AND NON-INVASIVE CARDIOVASCULAR INTERVENTION, DEVICES, AND SURGERIES 20. Iatrogenic Aspects of Non-Invasive and Invasive Diagnostic Methods in Interventional Cardiology C. Dösch, D. Loßnitzer, T. Papavassiliu 21. Iatrogenicity Associated with Interventional Treatment Modalities N.V. Pothineni, A. Garg, H. Paydak, and J.L. Mehta 22. Iatrogenicity of Diagnostic and Therapeutic, Invasive and Non-Invasive Cardiovascular Interventions, Devices and Surgeries M. Behnes, T. Becher, S. Baumann, and I. Akin 23. Iatrogenic Aspects in Cardiac Electrophysiology B. Rudic, E. Tülümen, and V. Liebe 24. Iatrogenic Aspects in Cardiac Device Therapy S. Röger and J. Kuschyk 25. Cardiovascular Iatrogencity of Respiratory Therapeutic Modalities M.S. Nolledo, P. Lerma and T.V. Santiago Part IV: IATROGENIC ASPECTS OF SPORT CARDIOLOGY AND LIFE-STYLE MODIFICATIONS 26. Professional Athletes G. Mancia 27. Sports Cardiology G. Campanile 28. Dangers of Lifestyle Modification Advice G. Campanile Part V: IATROGENICITY OF DIETARY SUPPLEMENTS, HERBAL PRODUCTS, AND OTHER NON-TRADITIONAL THERAPIES IN CARDIOVASCULAR MEDICINE 29. Safety of Over-the-Counter ‘Natural Substances’ and Vitamins: Side-effects and Contraindications S. Sultan, A. Jahangir, C. Ding, H. Cao, J.B. Kostis, I.B. Gussak, and A. Jahangir 30. Interactions Between Supplements and Prescription Medications S. Sultan, A. Jahangir, C. Ding, H. Cao, J.B. Kostis, I.B. Gussak, and A. Jahangir Acknowledgments Index
£105.40
Rutgers University Press Iatrogenicity Causes and Consequences of
Book SynopsisThis book addresses consequences on the cardiovascular system that arise from iatrogenesis— the occurrence of untoward effects resulting from actions of health care providers, including medical errors, medical malpractice, practicing beyond one’s expertise, adverse effects of medication, unnecessary treatment, inappropriate screenings, and surgical errors.Table of ContentsTABLE OF CONTENTS Part I: MEDICAL HARM 1. The Concept and Spectrum of "Iatrogenicity" I. Gussak and J. Kostis 2. Iatrogenicity: Definition, History and Modern Context M. Gussak, I. Gussak, and J. Kostis 3. Epidemiology and Public Health Aspects and Implications: Regulatory, Legal and Ethical Dimensions of Iatrogenicity S. Jones and M. Gonzalez 4. Risk Management: The Medical Center Administration Perspective S. Jones and M. Gonzalez 5. Iatrogenicity from the Patient's Perspective J. Dobrzynski, S. Jones, and M. Gonzalez 6. A Naturopathic Perspective on Iatrogenesis C. Fleetwood Part II: IATROGENICITY OF CARDIOVASCULAR DURGS AND CARDIOVASCULAR TOXICITY OF NON-CARDIAC DRUGS 7. Clinical Manifestations of Acute and Chronic Drug-Induced Iatrogenic Cardiovascular Diseases and Syndromes I. Gussak, G. Yan, A. Jahangir, and J. Kostis 8. Drug-Induced Cardiac Arrhythmias and Sudden Cardiac Death A. Narichania, Y. Yokoyama, and W.K. Shen 9. Chemotherapy-Induced Cardiomyopathies E. Birati and B. Jessup 10. Iatrogenicity of Blood Pressure Mesaurement in the Diagnosis of Hypertension T. Giles, G. Sander, I. Gussak, and J. Kostis 11. Antihypertensive Drug-Induced Iatrogenic Cardiovascular Syndromes R. Kalaitzidis and G. Bakris 12. Iatrogenicity of Cardiovascular Drugs Associated with Cardiac and Non-Cardiac Toxicities: Antihypertensive Agents and Biologics E. Hermes-Desantis and J. Barone 13. Iatrogenic Aspects of Hypertension in Pregnancy: Focus on Preeclampsia C. Thomopoulos and T. Makris 14. Women and Iatrogenic Cardiovascular Disease: Menopausal Estrogen as the Prime Suspect G. Bachmann, M. Rees, and N. Phillips 15. Iatrogenic Aspects of Lipid-Lowering Agents, Thrombolytic, Antiplatelet, and Antithrombotic Agents C. Tsioufis, D. Konstantinidis, N. Vogiatzakis, and K. Dimitriadis 16. Iatrogenic Effects of ‘Urologic' Drugs on the Cardiovascular System K. Stavropoulos, C. Boutari, K. Imprialos, and M. Doumas 17. Iatrogencity and Antianginal Drugs A. Moreyra and W.J. Kostis 18. Anti-Diabetic Drugs and Cardiovascular Risk: Where Do We Stand? R. Kumar 19. Cardiovascular Iatrogenicity in Older Adults A. Khan, #. Ali, #. Iyengar, #. Hagiwara, #. Periyakoil, #. Patel, #. Malone Part III: IATROGENCITY OF DIAGNOSTIC AND THERAPEUTIC, INVASIVE AND NON-INVASIVE CARDIOVASCULAR INTERVENTION, DEVICES, AND SURGERIES 20. Iatrogenic Aspects of Non-Invasive and Invasive Diagnostic Methods in Interventional Cardiology C. Dösch, D. Loßnitzer, T. Papavassiliu 21. Iatrogenicity Associated with Interventional Treatment Modalities N.V. Pothineni, A. Garg, H. Paydak, and J.L. Mehta 22. Iatrogenicity of Diagnostic and Therapeutic, Invasive and Non-Invasive Cardiovascular Interventions, Devices and Surgeries M. Behnes, T. Becher, S. Baumann, and I. Akin 23. Iatrogenic Aspects in Cardiac Electrophysiology B. Rudic, E. Tülümen, and V. Liebe 24. Iatrogenic Aspects in Cardiac Device Therapy S. Röger and J. Kuschyk 25. Cardiovascular Iatrogencity of Respiratory Therapeutic Modalities M.S. Nolledo, P. Lerma and T.V. Santiago Part IV: IATROGENIC ASPECTS OF SPORT CARDIOLOGY AND LIFE-STYLE MODIFICATIONS 26. Professional Athletes G. Mancia 27. Sports Cardiology G. Campanile 28. Dangers of Lifestyle Modification Advice G. Campanile Part V: IATROGENICITY OF DIETARY SUPPLEMENTS, HERBAL PRODUCTS, AND OTHER NON-TRADITIONAL THERAPIES IN CARDIOVASCULAR MEDICINE 29. Safety of Over-the-Counter ‘Natural Substances’ and Vitamins: Side-effects and Contraindications S. Sultan, A. Jahangir, C. Ding, H. Cao, J.B. Kostis, I.B. Gussak, and A. Jahangir 30. Interactions Between Supplements and Prescription Medications S. Sultan, A. Jahangir, C. Ding, H. Cao, J.B. Kostis, I.B. Gussak, and A. Jahangir Acknowledgments Index
£99.20
Rutgers University Press Ischemic Stroke Diagnosis and Treatment Current
Book SynopsisStroke is the fourth leading cause of death in the United States. Despite the frequency and morbidity of stroke, there is a relative paucity of “stroke experts” for these patients. Ischemic Stroke closes the gap in stroke care by providing a cogent and intuitive guide for all physicians caring for stroke patients.Table of ContentsTABLE OF CONTENTS 1 Emergent Evaluation of the Suspected Stroke Patient 2 Clinical Signs and Symptoms of Stroke 3 Mechanisms of Ischemic Stroke 4 Neuroimaging of Acute Stroke 5 Cardiac-Based Evaluation of Ischemic Stroke 6 Thrombolytic Therapy for Acute Ischemic Stroke 7 Endovascular Management of Acute Ischemic Stroke 8 Critical Care Management of Ischemic Stroke 9 Stroke Rehabilitation 10 Cardiac Arrhythmias and Stroke 11 Secondary Prevention of Cardiogenic Stroke 12 Treatment of Symptomatic Carotid Stenosis 13 Intracranial Large Vessel Disease 14 Small Vessel Disease 15 Cryptogenic Stroke Index
£99.20
John Wiley and Sons Ltd Atrial Tachycardia
Book SynopsisIn the course of understanding the mechanism and therapy of atrial tachycardia, important distinctions are emerging in electrophysical evaluations of various atrial arrhythmias. This is a review of the latest knowledge in the field.Table of ContentsIntroduction. II. Definitions. III. Electrophysiologic Mechanisms. 1. Reentry. 2. Abnormal Automaticity. 3. Triggered Activity. IV. Focal Atrial Tachycardia. 1. Clinical and Electrocardiographic Presentation. The Role of P Wave Configuration. Tachycardia-Induced Cardiomyopathy. Multifocal Atrial Tachycardia. 2. Electrophysiologic Characteristics and Diagnosis. 3. Therapy. The Role of Newer Technologies for Mapping and Ablation of Atrial Tachycardia. The Role of Atrial Anatomy. V. Atrial Fibrillation as a Manifestation of Focal Atrial Activation. 1. Clinical and Electrocardiographic Presentation. 2. Electrophysiologic Characteristics and Diagnosis. 3. Therapy. VI. Incisional Intraatrial Reentrant Tachycardia. 1. Clinical and Electrocardiographic Presentation. 2. Electrophysiologic Characteristics and Diagnosis. 3. Therapy. VII. Inappropriate Sinus Tachycardia. 1. Clinical and Electrocardiographic Presentation. 2. Electrophysiologic Characteristics and Diagnosis. 3. Therapy. VIII. Conclusion. References. Index.
£41.75
John Wiley and Sons Ltd Jesse E. Edwards Synopsis of Congenital Heart
Book SynopsisIn this book Dr Edwards shares his vast experience in a discussion of the fundamental anatomy and physiology associated with congenital heart disease. The text provides succinct descriptions of the common and uncommon abnormalities of congenital heart disease and the principles underlying their treatment, while 200 figures clearly demonstrate and guide the user to understand the essential nature of the characteristic defects and abnormalities discussed.Table of ContentsAcknowledgements. Foreword. Guest Preface. Preface. Recollections. Abbreviations. Variations of Bodily Organs. Atrial Anomalies. Ventricular Anomalies. Atrioventricular Cushion Defect. Myocardial Disease. Single Ventricle. Complete Transposition. Corrected Transposition. Double Outlet Right Ventricle. Tetralogy of Fallot. Anomalies of Pulmonary Arteries. Persistent Truncus Arteriosus. Anomalies of Coronary Vessels. Valvular and Related Anomalies. Aortic Atresia. Pulmonary Atresia. Mitral Atresia. Tricuspid Atresia. Aortic Stenosis. Subaortic Stenosis. Pulmonary Stenosis. Mitral Stenosis and Similar Functional Entities. Aortic Regurgitation. Pulmonary Regurgitation. Mitral Regurgitation. Tricuspid Dysplasia and Regurgitation in Ebstein's Malformation. Patent Ductus Arteriosis and AP Window. Aortic Sinus Aneurysm. Aortic Coarctation. Supravalvular Aortic Stenosis. Hypoplasia or Interruption of the Aortic Arch. Vascular Rings and Vascular Slings. Anomalies of Pulmonary Veins. Vena Caval Systems. Asplenia and Polysplenia. References. Index
£94.46
John Wiley and Sons Ltd Practical Management of Pediatric Cardiac
Book SynopsisPractical Management of Pediatric Cardiac Arrhythmias offers a useful source of current, practical information on the diagnosis and management of arrhythmias in children, and is intended for all caregivers, from novice to expert, who treat children, adolescents, and young adults with arrhythmias.Trade Review"The book serves as a useful source of current information and practical data regarding the diagnosis and management of pediatric arrhythmias and appeals to all aspects of caregiving. "Much of the book could serve as a nursing care manual. The approach is succinct and practical, deemphasizing electrophysiology basic science. "This is a valuable, practical addition to a field of medicine which is sometimes obscure. The book is very useful for the practicing nurse or physician." --Doody’s Review Service "I applaud the authors for their well-demonstrated effort to remember that treating the whole person in pediatrics means treating the whole family. Each of these sections not only reminds the clinician of the educational and emotional needs of the family of a child with a newly diagnosed arrhythmia, but also suggests strategies for promoting acceptance, understanding, and compliance. Overall, this book is an important addition to the library of any clinician who is involved in the care of a child with cardiac arrhythmias." --Critical Care NurseTable of ContentsForeword. Thomas P. Graham, Jr., MD. Chapter 1. Mechanisms, Diagnostic Tools, and Patient and Family Education. Vicki L. Zeigler, RN, MSN, Dianne Marlow, RN, BSN, CLNC and Paul C. Gillette, MD. Chapter 2. Supraventricular Arrhythmias. Sarah S. LeRoy RN, MSN, CPNP and Macdonald Dick II, MD. Chapter 3. Ventricular Arrhythmias. Vicki L. Zeigler, RN, MSN and Paul C. Gillette, MD. Chapter 4. Immediate Arrhythmia Management. Barbara J. Knick, RN, CVT and J. Phillip Saul, MD. Chapter 5. Long-Term Antiarrhythmic Drug Therapy. Debra G. Hanisch, RN, MSN, CPNP and George F. Van Hare, MD. Chapter 6. Radiofrequency Catheter Ablation. Dianne Marlow, RN, BSN, CLNC and Paul C. Gillette, MD. Chapter 7. Permanent Pacemakers. Sherry J. Taylor, RN, BSN, Vicki L. Zeigler, RN, MSN, and John M. Clark, MD. Chapter 8. Implantable Cardioverter Defibrillators. Vicki L. Zeigler, RN, MSN, Karen Corbett, PhD, RN, Ann Lewis, RN, BSN, and Paul C. Gillette, MD. Index
£100.76
John Wiley and Sons Ltd Chest Pain
Book SynopsisIntroduces the knowledge and skills needed to analyze symptoms, physical findings, and ECG and x-ray abnormalities in order to accurately diagnose more than 50 different conditions that may bring about a complaint of 'chest pain'. This book concentrates on causative syndromes or maladies, from its initial presentation to its etiology.Trade Review"This book...is worth owning. It is not going out of date next year!" William C. Roberts American Journal of CardiologyTable of ContentsPreface. Chapter 1. An Explanation of the Title and General Comments. J. Willis Hurst, M.D. PART I: Skin Disease as a Cause for "Chest Pain". Chapter 2. "Chest Pain" in Patients with Herpes Zoster (Shingles). Calvin O. McCall, M.D. and S. Wright Caughman, M.D.. PART II: Musculoskeletal Diseases as a Cause for "Chest Pain". Chapter 3. "Chest Pain" in Patients with Costochondritis or Tietze's Syndrome. Byron R. Williams, M.D.. Chapter 4. "Chest Pain" in Patients with Thoracic Outlet Syndromes. Vinod H. Thourani, M.D. and Joseph I. Miller, Jr., M.D.. Chapter 5. "Chest Pain" in Patients with Chest Wall Syndromes. J. Willis Hurst, M.D. Chapter 6. "Chest Pain" in Patients with the Shoulder-Hand Syndrome. Mark E. Silverman, M.D.. Chapter 7. "Chest Pain" in Patients with Bursitis of the Shoulder. Stephen B. Miller, M.D. Chapter 8. "Chest Pain" in Patients with Rotator Cuff Tendonitis or Arthritis of the Shoulder. Andrew P. Gutow, M.D. Chapter 9. "Chest Pain" in Patients with Joint Disease of the Cervical or Thoracic Spine. Stephen B. Miller, M.D.. PART III: Thrombophlebitis as a Cause for "Chest Pain". Chapter 10. "Chest Pain" in Patients with Mondor's Syndrome. Stephen D. Clements, Jr., M.D.. PART IV: Neurologic Disease as a Cause for "Chest Pain". Chapter 11. "Chest Pain" in Patients with Cervical Disc Syndromes. David J. Hewitt, M.D. Chapter 12. "Chest Pain" in Patients with Brachial Plexus Neuropathy. David J. Hewitt, M.D. PART V: Mediastinal Disease as a Cause for "Chest Pain". Chapter 13. "Chest Pain" in Patients with Mediastinal Emphysema. Talmadge E. King, Jr., M.D. PART VI: Pulmonary Causes of "Chest Pain". Chapter 14. "Chest Pain" in Patients with Pleuritis. Talmadge E. King, Jr., M.D.. Chapter 15. "Chest Pain" in Patients with Pneumothorax. Talmadge E. King, Jr., M.D.. Chapter 16. "Chest Pain" in Patients with Pulmonary Embolism. Nanette K. Wenger, M.D. Chapter 17. "Chest Pain" in Patients with "Café" Coronary. Stephen D. Clements, Jr., M.D. PART VII: Diseases of the Gastrointestinal Tract as a Cause for "Chest Pain". Chapter 18. "Chest Pain" in Patients with Esophageal Motility Disorders. J. Patrick Waring, M.D. Chapter 19. "Chest Pain" in Patients with Gastroesophageal Reflux. J. Patrick Waring, M.D. Chapter 20. "Chest Pain" in Patients with Esophageal Rupture. J. Patrick Waring, M.D. Chapter 21. "Chest Pain" in Patients with Esophageal Stenosis. J. Patrick Waring, M.D. Chapter 22. "Chest Pain" in Patients with Pill-Induced Esophagitis. J. Patrick Waring, M.D. Chapter 23. "Chest Pain" of Esophageal Origin in Patients with HIV. J. Patrick Waring, M.D.. Chapter 24. "Chest Pain" in Patients with Peptic Ulcer Disease. Steve Goldschmid, M.D. PART VIII: Diseases of the Gallbladder and Biliary Tract as Causes of "Chest Pain". Chapter 25. "Chest Pain" in Patients with Biliary Colic. Steve Goldschmid, M.D. Chapter 26. "Chest Pain" in Patients with Acute Cholecystitis. Steve Goldschmid, M.D. PART IX: Pericardial Disease as a Cause for "Chest Pain". Chapter 27. "Chest Pain" in Patients with Acute Pericarditis. David H. Spodick, MD, DSc. PART X: Heart Disease as a Cause for "Chest Pain". Chapter 28. "Chest Pain" in Patients with Cardiac Arrhythmias. Paul F. Walter, M.D. and J. Willis Hurst, M.D.. Chapter 29. "Chest Pain" in Patients with Angina Pectoris. J. Willis Hurst, M.D. Chapter 30. "Chest Pain" in Patients with Myocardial Infarction. Douglas C. Morris, M.D. Chapter 31. "Chest Pain" in Patients with Prinzmetal''s Angina. David Waters, M.D. and Rabih R. Azar, M.D., M.Sc. Chapter 32. "Chest Pain" in Patients with Myocardial Infarction with Normal or Near Normal Coronary Arteriogram. Rabih R. Azar, M.D., M.Sc. and David Waters, M.D.. Chapter 33. "Chest Pain" in Patients Who Use Cocaine. Jessica Haberer, M.D. and David Waters, M.D.. Chapter 34. "Chest Pain" in Patients with Congenital Heart Disease. Joseph K. Perloff, M.D.. Chapter 35. "Chest Pain" in Patients with Aortic Valve Stenosis. Douglas C. Morris, M.D. Chapter 36. "Chest Pain" in Patients with Aortic Valve Regurgitation. Douglas C. Morris, M.D. Chapter 37. "Chest Pain" in Patients with Rheumatic Mitral Valve Stenosis. Douglas C. Morris, M.D. Chapter 38. "Chest Pain" in Patients with Hypertrophic Cardiomyopathy. Douglas C. Morris, M.D.. Chapter 39. "Chest Pain" in Patients with Dilated Cardiomyopathy. Douglas C. Morris, M.D. Chapter 40. "Chest Pain" in Patients with Restrictive Cardiomyopathy. Douglas C. Morris, M.D. Chapter 41. "Chest Pain" in Patients with Pulmonary Hypertension. Robert C. Schlant, M.D. Chapter 42. "Chest Pain" in Patients with Systemic Hypertension. J. Willis Hurst, M.D. PART XI: "Chest Pain" Caused by Diseases of the Aorta. Chapter 43. "Chest Pain" in Patients with Aortic Dissection. Joseph Lindsay, Jr., M.D. Chapter 44. "Chest Pain" in Patients with Aortic Aneurysms. Joseph Lindsay, Jr., M.D. PART XII: "Chest Pain" Related to Emotional or Psychiatric Conditions. Chapter 45. "Chest Pain" in Patients with Anxiety Disorders. Bernard L. Frankel, M.D.. Chapter 46. "Chest Pain" in Patients with Depressive Disorders. Bernard L. Frankel, M.D.. Chapter 47. "Chest Pain" in Patients Who Are Malingering. James C. Hamilton, Ph.D. and Marc D. Feldman, M.D.. Chapter 48. "Chest Pain" in Patients with Factitious Disorder Including Munchausen Syndrome. Marc D. Feldman, M.D. and James C. Hamilton, Ph.D.. Chapter 49. "Chest Pain" in Patients with Addiction. Karen Drexler, M.D.. PART XIII: "Chest Pain" of Controversial Origin. Chapter 50. "Chest Pain" in Patients with Syndrome X. Richard O. Cannon III, M.D.. Chapter 51. "Chest Pain" in Patients with Mitral Valve Prolapse. J. Willis Hurst, M.D.. PART XIV: Final Comments. Chapter 52. The Evolution of our Knowledge and Remaining Problems. J. Willis Hurst, M.D.
£80.70
John Wiley and Sons Ltd Assessing and Modifying the Vulnerable
Book SynopsisEdited by Valentin Fuster, former Chairman of the American Heart Associationa s Committee on Vascular Lesions, Assessing and Modifying the Vulnerable Atherosclerotic Plaque explores the cutting--edge developments in a steadily advancing field.Table of ContentsHistorical Perspective. Contributors. Chapter 1. Evolving Concepts of Atherothrombosis (Valentin Fuster, MD, PhD and Roberto Corti, MD). Chapter 2. Cerebrovascular Diseases: Pathophysiology and Management (Debabrata Mukherjee, MD and Jay S. Yadav, MD). Chapter 3. Aortic Arch Vulnerable Plaques: Update (Pierre Amarenco, MD and Ariel Cohen, MD, PhD). Chapter 4. The Vulnerable Atherosclerotic Plaque in Peripheral Vascular Disease (Michael L. Marin, MD, Larry H. Hollier, MD, Valentin Fuster, MD, PhD, and Jeffrey Goldman, MD). Panel Discussion I. Overview of Pathology: Clinical Correlations of Atherosclerosis. Chapter 5. Thermography: A Novel Approach for Identification of Plaques at Risk of Rupture and/or Thrombosis (Mohammad Madjid, MD, Morteza Naghavi, MD, James T. Willerson, MD, and Ward Casscells, MD). Chapter 6. Intravascular Ultrasound and Plaque Vulnerability: Evidence of a Systemic Disease Process (Paul Schoenhagen, MD and Steven E. Nissen, MD, FACC). Chapter 7. Intracoronary Angioscopy to Detect Vulnerable Plaques: A Technique Whose Time Has Come? (Sergio Waxman, MD). Chapter 8. Electron Beam Computed Tomography in Assessing the Vulnerable Atherosclerotic Plaque (Robert A. O'Rourke, MD). Chapter 9. Multirow-Detector Helical Computed Tomography (Christoph R. Becker, MD, Uwe J. Schoepf, MD, and Maximilian F. Reiser, MD). Panel Discussion IIA. Overview of Imaging: Coronary Atherosclerosis. Chapter 10. Imaging of the High-Risk Plaque Using Magnetic Resonance Imaging (Zahi A. Fayad, PhD and Valentin Fuster, MD, PhD). Chapter 11. Cardiovascular Imaging with Optical Coherence Tomography (Mark E. Brezinski, MD, PhD and James Fujimoto, PhD). Panel Discussion IIB. Overview of Imaging: Atherosclerotic Regions and Imaging Modalities. Chapter 12. Plaque Instability and Remodeling: Mechanisms and Possible Misconceptions (Trine-Line Korsholm, MS, Gerard Pasterkamp, MD, PhD, MSc, and Erling Falk, MD, PhD). Chapter 13. Structural and Cellular Components of the Vulnerable Plaque: Extracellular Matrix (Renu Virmani, MD, Frank D. Kolodgie, PhD, Allen P. Burke, MD, Andrew Farb, MD, and Thomas N. Wight, PhD). Chapter 14. Structural and Cellular Components of the Vulnerable Plaque: Inflammatory Cells (Allard C. van der Wal, MD, PhD, Mischa A. Houtkamp, MSc, Onno J. de Boer, PhD, and Anton E. Becker, MD, PhD). Panel Discussion III. Structural and Cellular Components of the Vulnerable Atherosclerotic Plaque. Chapter 15. Stress and Strain: Biomechanical Guides for Imaging Plaque Stability (Hayden Huang, DSc and Richard T. Lee, MD). Chapter 16. Endothelium, Flow, and Atherothrombosis (Roberto Corti, MD, Lina Badimon, PhD, Valentin Fuster, MD, PhD, and Juan Jose Badimon, PhD). Chapter 17. Activities that Trigger Plaque Disruption (Jagmeet P. Singh, MD, DM, PhD, James Januzzi, MD, and James E. Muller, MD). Panel Discussion IV. Mechanical Forces in Plaque Disruption. Chapter 18. Matrix Metalloproteinases and Their Inhibitors (Uwe Schönbeck, PhD and Peter Libby, MD). Chapter 19. Calcium Deposition in Vulnerable Atherosclerotic Plaques: Pathophysiologic Mechanisms and Potential Implications in the Acute Coronary Syndromes (Pedro R. Moreno, MD). Panel Discussion V. Regulation of Functional Components of the Vulnerable Plaque. Index.
£166.46
John Wiley and Sons Ltd Clinical Approaches to Tachyarrhythmias The Long
Book SynopsisThe long QT syndrome has become the focus of considerable scientific attention because of the discovery of several genes responsible for its development. This book provides an account of this syndrome's history, significance. It shows why the long QT syndrome has been the focus for numerous theories of arrhythmogenesis.Table of ContentsForeword. Preface. Introduction. Historical Note. Electrophysiology Mechanisms for Arrhythmias. Clinical Presentation. Molecular Biology of LQTS. Epidemiology. Diagnosis. Therapy. Conclusion. Index.
£41.75
John Wiley and Sons Ltd Cardiovascular Prevention and Rehabilitation in
Book SynopsisThe second edition of this textbook builds on the success of the original version by incorporating the latest developments in the clinical evidence base for cardiac rehabilitation whilst also aligning with the wider agenda in terms of commissioning and other national guidance.Table of ContentsForeword vii List of Contributors ix Preface xiii Chapter 1 Cardiovascular Disease Prevention and Rehabilitation 1Jennifer Jones, Gill Furze, and John Buckley Chapter 2 Standards and Core Components in Cardiovascular Disease Prevention and Rehabilitation 21BACPR Standards Writing Group Chapter 3 Delivering Quality Standards 47Kathryn Carver Chapter 4 Health Behaviour Change and Education 67Linda Speck, Gill Furze, and Nick Brace Chapter 5 Lifestyle Risk Factor Management 99Jennifer Jones, John Buckley, and Gill Furze Chapter 5A Achieving Long‐term Abstinence from Tobacco Use in Patients in a Cardiovascular Prevention and Rehabilitation Setting 101Catriona Jennings and Robert West Chapter 5B Diet and Weight Management 127Alison Atrey and Rachel Vine Chapter 5C Physical Activity and Exercise 151John Buckley, Tim Grove, Sally Turner, and Samantha Breen Chapter 6 Psychosocial Health 193Linda Speck, Nick Brace, and Molly Byrne Chapter 7 Medical Risk Management 227Joe Mills, Susan Connolly, Barbara Conway, Marie-Kristelle Ross, Samantha Breen, and Dorothy J. Frizelle Chapter 8 Long‐term Management 271Sally Hinton, Ann Marie Johnson, and Gail Sheppard Chapter 9 Audit and Evaluation 285Patrick Doherty, Alex Harrison, Corinna Petre, and Nerina Onion Chapter 10 Future Prospects and International Perspectives 305Joe Mills, Sherry L. Grace, Marie‐Kristelle Ross, Caroline Chessex, Robyn Gallagher, Cate Ferry, and Vicki Wade Index 313
£49.35
John Wiley and Sons Ltd The Nuts and Bolts of Implantable Device Therapy
Book SynopsisThis book provides an excellent introductory resource for those new to cardiac pacing and pacemakers.Table of ContentsPreface, vi Acknowledgments, vii 1 Cardiovascular anatomy and physiology, 1 2 Cardiac conduction system, 15 3 The cardiac cycle and hemodynamics, 21 4 Heart disease, 29 5 Cardiac medications related to cardiac rhythm management devices, 37 6 The basics of ecg and rhythm interpretation, 48 7 Arrhythmia analysis, 58 8 E lectricity 101, 78 9 Pacing 101, 84 10 Indications for pacing, 104 11 Pacemaker implantation, 116 12 Connecting the leads to the pulse generator, 131 13 Pacemaker modes and codes, 140 14 Single-chamber timing cycles, 153 15 Introduction to dual-chamber timing cycles, 169 16 Dual-chamber timing cycles: the atrial channel, 179 17 Dual-chamber timing cycles: the ventricular channel, 195 18 Paced ECG and EGM analysis, 205 19 Upper-rate behavior, 219 20 Advanced dual-chamber timing, 233 21 Rate-responsive pacing, 242 22 Special features, 260 23 Automatic capture algorithms, 278 24 Pacemaker follow-up, 297 25 Follow-up and troubleshooting, 310 Key answer, 316 Index, 320
£51.25
John Wiley and Sons Ltd Medical Student Survival Skills
Book SynopsisMedical students encounter many challenges on their path to success, from managing their time, applying theory to practice, and passing exams. The Medical Student Survival Skills series helps medical students navigate core subjects of the curriculum, providing accessible, short reference guides for OSCE preparation and hospital placements. These guides are the perfect tool for achieving clinical success. Medical Student Survival Skills: ECG is an indispensable resource for students new to ECG interpretation and cardiac arrhythmia recognition and treatment. Integrating essential clinical knowledge with practical OSCE advice, this portable guide provides concise and user-friendly coverage of all aspects of ECG monitoring, including atrial and ventricular fibrillation, myocardial infarction, and 12 lead ECG interpretation. Easy-to-find information, plentiful illustrations, OSCE checklists and expert discussions of actual ECG trace examples help medical students andTable of ContentsPreface vii About the companion website ix 1 Introduction to ECG monitoring 1 2 Principles of ECG monitoring 3 3 Six stage approach to ECG interpretation 9 4 Sinus tachycardia 13 5 Sinus bradycardia 15 6 Sinus arrhythmia 17 7 Atrial ectopic beats 19 8 Atrial tachycardia 21 9 Atrial flutter 23 10 Atrial fibrillation 27 11 AV junctional ectopics 31 12 AV junctional escape rhythm 33 13 Junctional tachycardia 35 14 Ventricular ectopics 37 15 Idioventricular rhythm 41 16 Ventricular tachycardia 43 17 Torsades de pointes 47 18 First degree AV block 49 19 Second degree AV block Mobitz type I (Wenckebach phenomenon) 51 20 Second degree AV block Mobitz type II 53 21 Third degree (complete) AV block 55 22 Ventricular fibrillation 59 23 Ventricular standstill 61 24 Asystole 63 25 Recording a 12 lead ECG 65 26 What the standard 12 lead ECG records 71 27 Interpretation of a 12 lead ECG 75 28 ECG changes associated with myocardial infarction 81 29 ECG changes associated with myocardial ischaemia 87 30 ECG changes associated with bundle branch block 91 31 Wolff–Parkinson–White syndrome 97 Appendix A: Resuscitation council (UK) bradycardia algorithm 99 Appendix B: Resuscitation council (UK) tachycardia algorithm 101 Appendix C: Resuscitation council (UK) advanced life support (ALS) algorithm 103 Appendix D: Vagal manoeuvres 105 Appendix E: Synchronised electrical cardioversion 107 Appendix F: External (transcutaneous) pacing 111 Appendix G: Procedure for transcutaneous pacing 113 Appendix H: Definitions 115 References 117 Index 119
£25.60
John Wiley & Sons Inc Preventing Reversing Heart Disease For Dummies
Book SynopsisThe safe and trusted way to prevent and reverse heart disease Written in plain English and packed with tons of authoritative advice, Preventing & Reversing Heart Disease For Dummies includes the most up-to-date information on coronary heart disease and its treatment.Table of ContentsIntroduction 1 Part I: Getting Started with Preventing and Reversing Heart Disease 5 Chapter 1: Taking Charge of Your Heart Health 7 Chapter 2: Understanding the Onset and Outcomes of Heart Disease 15 Chapter 3: Are You at Risk of Heart Disease? How to Turn That Risk Around 39 Part II: Taking Basic Steps to Heart Health 51 Chapter 4: Forming a Partnership with Your Doctor for the Best Heart Care 53 Chapter 5: Embracing a Healthy Diet and Active Lifestyle 65 Chapter 6: Tapping the Power of the Mind/Body Connection 89 Chapter 7: Taking a Family Approach to Preventing Heart Disease 101 Part III: Tackling Key Health Risks for Heart Disease 111 Chapter 8: Combating High Blood Pressure 113 Chapter 9: Managing Bad (and Good) Cholesterol 129 Chapter 10: Managing Your Weight to Lower Your Risk 143 Chapter 11: Quitting Smoking 157 Part IV: Treating Heart Disease 169 Chapter 12: Modern Medical Arsenal: Rx Weapons for Heart Disease 171 Chapter 13: The 411 on Invasive and Surgical Procedures 189 Chapter 14: Exploring Complementary Therapies 201 Chapter 15: Taking Back Your Life after a Heart Event 213 Part V: Heart-Healthy Recipes 225 Chapter 16: Heart-Healthy Breakfasts 227 Chapter 17: Heart-Healthy Lunches 243 Chapter 18: Heart-Healthy Dinners 263 Chapter 19: Snacks, Starters, and Desserts 287 Part VI: The Part of Tens 299 Chapter 20: Ten Differences in Heart Disease between Women and Men 301 Chapter 21: Ten Cardiac Symptoms You Shouldn’t Ignore 307 Chapter 22: Ten Heart Tests to Consider or Avoid 311 Chapter 23: Ten Tips for Involving Your Family in a Heart-Healthy Lifestyle 317 Appendix: Metric Conversion Guide 323 Index 325
£17.09
John Wiley and Sons Ltd ECG from Basics to Essentials
Book SynopsisTable of ContentsPreface, vi About the companion website, vii 1 Anatomy and Basic Physiology, 1 2 ECG Recording and ECG Leads, 21 3 The Normal ECG and the Frontal Plane QRS Axis, 53 4 The Components of the ECG Waves and Intervals, 73 5 P waves and Atrial Abnormalities, 85 6 Chamber Enlargement and Hypertrophy, 99 7 Intraventricular Conduction Defects, 105 8 Coronary Artery Disease and Acute Coronary Syndromes, 123 9 Acute Pericarditis, 187 10 The ECG in Extracardiac Disease, 193 11 Sinus Node Dysfunction, 203 12 Premature Ventricular Complexes (PVC), 217 13 Atrioventricular Block, 227 14 Atrial Rhythm Disorders, 243 15 Ventricular Tachycardias, 279 16 Ventricular Fibrillation and Ventricular Flutter, 305 17 Preexcitation and Wolff -Parkinson-White Syndrome (WPW), 311 18 Electrolyte Abnormalities, 327 19 Electrophysiologic Concepts, 333 20 Antiarrhythmic Drugs, 351 21 Pacemakers and their ECGs, 359 22 Errors in Electrocardiography Monitoring, Computerized ECG, Other Sites of ECG Recording, 391 23 How to Read an ECG, 407 Index, 425
£45.55
John Wiley and Sons Ltd Rapid Cardiac Care
Book SynopsisRapid Cardiac Care is an indispensable resource for all frontline staff working with acutely ill patients. Offering easy access to the knowledge base needed to provide rapid, safe and effective cardiac care, it is ideal for newly qualified healthcare professionals including, nurses, paramedics, cardiac technicians, junior medics, and physiotherapists. Key features include: Essential information to support the assessment of the cardiac patient including focused history taking and physical assessment, rhythm interpretation and 12-lead ECG assessmentPractical guidance on how to care for patients with cardiac emergencies, including acute coronary syndromes, arrhythmias, heart failure and cardiac arrestA quick reference A-Z section that explores a wide range of conditions affecting the heart, each with a comprehensive overview of patient presentation and strategies to guide patient assessment and managementDiagrams and images are provided to facilitate learningTable of ContentsList of Abbreviations ix Preface xii Acknowledgements xiii Part 1: Cardiac Anatomy and PhysiologyAnatomy 3 Cardiac cycle 5 Cardiac conduction system 6 Coronary circulation 8 Part 2: Rapid Cardiac AssessmentIntroduction 13 Cardiac history taking 14 Physical examination 18 Cardiac Monitoring 21 Rapid rhythm recognition 23 Cardiac investigations 25 Part 3: Rapid 12‐lead ECG InterpretationIntroduction 31 Cardiac vectors and axis 33 Rapid ECG analysis tool 34 Rate and rhythm assessment 35 QRS axis calculation 36 Pre‐excitation syndromes 37 Bundle branch block and fascicular block 38 Myocardial ischaemia or infarction 41 Other abnormalities seen on the 12‐lead ECG 44 Part 4: Cardiac Conditions A–ZAcute coronary syndromes 47 Acute coronary syndromes: treatment and interventions 51 Acute heart failure 54 Aortic aneurysm 57 Aortic dissection 59 Aortic regurgitation 61 Aortic stenosis 63 Arrhythmogenic right ventricular cardiomyopathy 65 Atrial fibrillation 67 Atrial flutter 69 Brugada syndrome 71 Cardiac arrest 73 Cardiac arrhythmias: treatment and interventions 75 Cardiogenic shock 79 Dilated cardiomyopathy 81 Heart blocks 83 Hypertension 86 Hypertrophic cardiomyopathy 88 Infective endocarditis 90 Long QT syndrome 92 Marfan syndrome 94 Mitral regurgitation 96 Mitral stenosis 98 Myocarditis 100 Pericarditis 102 Supraventricular tachycardia 104 Takotsubo cardiomyopathy 107 Ventricular tachycardia 109 Wolff‐Parkinson‐White syndrome (Pre‐excitation syndrome) 111 Index 113
£28.45
John Wiley and Sons Ltd Cardiac Problems in Pregnancy
Book SynopsisCardiac Problems in Pregnancy offers clinicians the most detailed and comprehensive guide to diagnosing and managing pregnancy-associated cardiovascular diseases currently available. Covering a wide spectrum of congenital and acquired cardiovascular conditions, its extensive contents examine diseases of the heart with an expert awareness of the implications of pregnancy and the attendant physiological changes it brings. Such guidance is vitally required in an age in which congenital and acquired heart diseases are the leading causes of non-obstetrical maternal morbidity and mortality. Featuring 36 new or extensively revised chapters, this fourth edition of the book complements coverage of the latest research and clinical advances with a complete and up-to-date bibliography of literature on pregnancy in women with cardiovascular conditions. It also serves as a practical, step-by-step companion for those caring for heart disease patients during pregnancy, labor, and theTable of ContentsAbout the Editor ix List of Contributors x Preface xiii Acknowledgments xiv Part I Physiologic Changes During Normal Pregnancy and the Puerperium 11 Hemodynamic and Cardiac Function 3Ofer Havakuk and Uri Elkayam Part II Cardiac Evaluation of the Pregnant Woman 17 2 Cardiovascular Evaluation During Pregnancy 19Uri Elkayam 3 Cardiovascular Imaging in the Pregnant Patient 32Patrick Colletti and Uri Elkayam Part III Cardiac Disorders and Pregnancy 41 4 Risk Assessment Prior and During Pregnancy 43Samuel C. Siu and Candice K. Silversides 5 Congenital Heart Disease and Pregnancy 60Candice K. Silversides, Jack M. Colman, and Samuel C. Siu 6 Native Valvular Heart Disease and Pregnancy 75Uri Elkayam 7 Pregnancy in the Patient with Prosthetic Heart Valves 90Uri Elkayam 8 Myocarditis and Pregnancy 107Avraham Shotan and Andrei Keren 9 Pericardial Disorders and Pregnancy 116Marla A. Mendelson 10 Peripartum Cardiomyopathy 128Sorel Goland and Uri Elkayam 11 Dilated Cardiomyopathy and Pregnancy 155Kathleen Stergiopoulos and Fabio V. Lima 12 Hypertrophic Cardiomyopathy and Pregnancy 167Iris M. van Hagen, Uri Elkayam, Sorel Goland, and Jolien W. Roos-Hesselink 13 Left Ventricular Noncompaction 181Radha J. Sarma 14 Acute Myocardial Infarction and Pregnancy 201Uri Elkayam and Ofer Havakuk 15 Cardiac Arrhythmias and Pregnancy 220Danna Spears and Uri Elkayam 16 Pulmonary Arterial Hypertension and Pregnancy 252Dianne Zwicke, Sara Paulus, and Vinay Thohan 17 Infective Endocarditis 261Ramin Ebrahimi, Michael Shenoda, Sheila Sahni, and David Fisk Part IV Vascular Disease in Pregnancy 275 18 Vascular Dissections and Aneurysms During Pregnancy 277Afshan B. Hameed 19 Marfan Syndrome and Pregnancy 285Sorel Goland and Uri Elkayam 20 Non-Marfan Aortopathies and the Pregnant Patient 305John Bois and Heidi Connolly 21 Takayasu’s Arteritis and Pregnancy 319Abha Khandelwal 22 Thromboembolic Disease in Pregnancy 326Courtney C. Bilodeau and Karen Rosene-Montella 23 Amniotic Fluid Embolism and Pregnancy 334Irene A. Stafford, Steven L. Clark, and Gary A. Dildy 24 Hypertension During Pregnancy 339Chonyang L. Albert and Leslie Cho 25 Syncope in Pregnancy 349Paul S. Gibson Part V Cardiac Surgery and Catheter Based Interventions During Pregnancy 359 26 Cardiac Surgery During Pregnancy 361Anita Nguyen and Hartzell V. Schaff 27 Catheter-Based Interventions in Women with Heart Disease During Pregnancy 370Anil Mehra, Gassan Muadi, Pavan Reddy, and Uri Elkayam 28 Analgesia and Anesthesia During Pregnancy, Labor, and Delivery 389Katherine W. Arendt 29 Cardiopulmonary Resuscitation of Pregnant Women 397Joan Briller 30 Pregnancy After Cardiac Transplantation 419Serban Constantinescu, Dawn P. Armenti, Lisa A. Coscia, Lynn R. Punnoose, John M. Davison, and Michael J. Moritz Part VI Cardiovascular Drug Therapy During Pregnancy 433 31 Pharmacokinetics of Drugs in Pregnancy and Lactation 435Irving Steinberg 32 Cardiovascular Drugs in Pregnancy and Lactation 456Petronella G. Pieper, Uri Elkayam, Joy Eskandar, and Titia P.E. Ruys 33 Tocolytic Therapy in the Cardiac Patient 491Joseph G. Ouzounian 34 Fertility Control in the Cardiac Patient 497Joan Briller, Mark R. Johnson, and Jolien W. Roos-Hesselink Part VII Labor and Delivery 513 35 Management of Labor and Delivery in a Cardiac Patient 515Rohan D’Souza and Mathew Sermer 36 Cardiac Effects of Drugs Used for Induction of Labor and Prevention and Treatment of Postpartum Hemorrhage 530Mark R. Johnson Index 537
£139.45
John Wiley and Sons Ltd Electrocardiography in Ischemic Heart Disease
Book SynopsisA fresh assessment of ischemic electrocardiography, its prognostic correlations, and the concepts and principles that underlie its use The electrocardiogram (ECG) is integral to the accurate diagnosis and optimal management of patients with ischemic heart disease. Picking up a wide range of indicators, it provides valuable prognostic data to cardiologists and emergency medicine specialists for whom ECG readings are a trusted and everyday resource. Electrocardiography in Ischemic Heart Disease is designed to help enhance such clinicians'' understanding of ECG recordings and their relationship to anatomical patterns of myocardial ischemia, thereby facilitating the continued improvement of patient care. For this new edition, the book''s globally recognized team of authors has revised and expanded the original text to bring it up to date with the cardiology of today. Practical explanations of electrophysiological mechanisms, ischemic insults, and arterial occlusions Table of ContentsForeword to the Second Edition vii Foreword to the First Edition ix Introduction xi Part I The ECG Changes Secondary to Ischemic Heart Disease: Electrophysiologic Bases 1 1 Anatomy of the Heart: The Importance of Imaging Techniques Correlations 3 2 Electrophysiological Bases of Ischemic Heart Disease 27 3 T Wave Changes 41 4 ST‐segment Changes 69 5 QRS and Other Waves Changes 81 Part II The ECG in Different Clinical Settings of Ischemic Heart Disease: Correlations and Prognostic Implications 95 6 The Role of the ECG in Patients with Acute Chest Pain 97 7 Acute Coronary Syndrome with ST Elevation (STE‐ACS) 111 8 ST‐Segment Elevation: Differentiating ST‐Elevation Myocardial Infarction from Non‐Ischemic ST Elevation 181 9 Acute Coronary Syndrome without ST‐Segment Elevation 207 10 Common Mistakes in the Diagnosis of Acute Coronary Syndromes 231 11 ECG in Complications of Acute Coronary Syndromes 249 12 Myocardial Infarction with and without Q Wave or Equivalent 277 13 Silent Ischemia 345 14 The ECG as a Predictor of Ischemic Heart Disease 353 15 Telemedicine in the Diagnosis of Ischemic Heart Disease Through the Surface Electrocardiogram 355 References 369 Index 401 Color plate section can be found facing page 180
£134.95
John Wiley & Sons Inc Clinical Electrocardiography
Book Synopsisb>Clinical Electrocardiography Electrocardiography is a transthoracic recording over a period of time. Electrical activity is detected and recorded via electrodes attached to the outer surface of the skin. The recording produced by this noninvasive procedure is termed as electrocardiogram. ECGs are used to measure the rate and regularity of heartbeats as well as the size and position of the chambers, the presence of any damage to the heart, and the effects of drugs or devices used to regulate the heart. Clinical Electrocardiography is the clearest and most accessible guide available to the application and interpretation of the ECG in clinical practice. The book proceeds from the belief that ECG patterns should not be memorized, but rather must be understood based on how they originate; it is only by achieving this level of understanding that clinicians can make the most informed diagnoses and thus manage patient care with complete confidence. This fully revised 5Table of ContentsPreface by Prof. Antoni Bayés de Luna vii Preface by Drs Miquel Fiol‐Sala, Antoni Bayes‐Genís, and Adrián Baranchuk viii Foreword by Dr Marcelo V. Elizari ix Foreword by Dr Pedro Brugada xi Recommended Reading xiii Part 1 Introductory Aspects 1 The Electrical Activity of the Heart 3 2 The History of Electrocardiography 11 3 Utility and Limitations of the Surface ECG: Present and Future 17 Part 2 The Normal ECG 4 The Anatomical Basis of the ECG: From Macroscopic Anatomy to Ultrastructural Characteristics 25 5 The Electrophysiological Basis of the ECG: From Cell Electrophysiology to the Human ECG 35 6 The ECG Recording: Leads, Devices, and Techniques 56 7 Characteristics of the Normal Electrocardiogram: Normal ECG Waves and Intervals 69 8 Diagnostic Criteria: Sensitivity, Specificity, and Predictive Value 100 Part 3 Abnormal ECG Patterns 9 Atrial Abnormalities 107 10 Ventricular Enlargement 133 11 Ventricular Blocks 170 12 Ventricular Pre‐excitation 215 13 Ischemia and Necrosis 229 Part 4 Arrhythmias 14 Mechanisms, Classification, and Clinical Aspects of Arrhythmias 299 15 Active Supraventricular Arrhythmias 321 16 Active Ventricular Arrhythmias 350 17 Passive Arrhythmias 376 18 Diagnosis of Arrhythmias in Clinical Practice: A Step‐by‐Step Approach 396 Part 5 The Clinical Usefulness of Electrocardiography 19 The Diagnostic Value of Electrocardiographic Abnormalities 411 20 The ECG in Different Clinical Set of Ischemic Heart Disease 427 21 Inherited Heart Diseases 478 22 The ECG in Other Heart Diseases 498 23 The ECG in Other Diseases and Different Situations 520 24 Other ECG Patterns of Risk 539 25 Limitations of the Conventional ECG: Utility of Other Techniques 552 26 The Electrocardiology of the Twenty‐First Century 571 Index 574
£98.06
John Wiley and Sons Ltd Essential Manual of 24Hour Blood Pressure
Book SynopsisTable of ContentsAuthor biography, xi Preface – Direction to “Perfect 24-hour Blood Pressure Control”, xv Acknowledgments, xix 1 Evidence and scientific rationale for ambulatory blood pressure monitoring (ABPM), 1 Diurnal BP variation and the concept of “perfect 24-hour BP control”, 1 Nocturnal hypertension and nocturnal BP dipping status, 3 Nocturnal BP dipping status, 3 Non-dipper patterns of BP and pulse rate, 3 Riser pattern of BP and cardiovascular disease risk, 4 Riser pattern and HF, 7 Riser pattern and brain damage, 15 Nocturnal hypertension, 17 Associated Conditions and Mechanisms of Nocturnal Hypertension, 20 Mechanism of cardiovascular risk of nocturnal hypertension, 22 Extreme dipping, 24 Morning surge in BP, 27 Definition of MBPS, 33 Morning BP surge and cardiovascular disease, 34 Morning BP surge and organ damage, 37 Determinants of MBPS, 43 Mechanism of morning risk, 44 Morning BP surge and hemostatic abnormalities, 46 Vascular mechanism of exaggerated morning BP surge, 49 BP Variability and systemic hemodynamic atherothrombotic syndrome (SHATS), 52 The resonance hypothesis of BP surge, 53 Orthostatic hypertension, 54 Ambulatory BP variability, 57 Visit-to-visit variability in office BP, 58 Vicious cycle between BP variability and vascular disease—SHATS, 59 White-coat and masked hypertension, 71 White-coat hypertension, 73 Masked hypertension, 75 Advances in ABPM, 75 Development of information and communication technology-based multi-sensor (IMS)-ABPM, 75 New ABPM indices, 77 HI-JAMP registry, 82 2 Scientific rationale for HBPM, 85 Five prospective, general practitioner-based, home BP studies, 85 Morning hypertension, 85 Control status of morning home BP in the J-HOP study, 88 Evidence for morning hypertension control, 89 Home BP variability, 99 Morning–evening difference (ME-dif), 99 SD, CV, ARV, and VIM of home BP, 101 Maximum home SBP, 103 Orthostatic Home BP Change, 103 Seasonal variation of home BP and “thermosensitive hypertension”, 109 Alcohol, 113 Daytime hypertension (stress hypertension), 115 Nighttime HBPM, 115 Cutting-edge of HBPM, 115 Basic nighttime home BP monitoring (Medinote), 119 Clinical evidence using nocturnal HBPM: J-HOP nocturnal BP study, 119 Trigger nighttime BP monitoring, 127 IT-based trigger nighttime BP monitoring system and the SPREAD study, 133 CPAP adherence and nighttime BP surge, 135 Antihypertensive medication on nighttime BP surge, 139 Wrist home HBPM and WISDOM Night study, 145 3 Practical use of ABPM and HBPM, 147 Concept and positioning of ABPM and HBPM in guidelines, 147 Recent guidelines, 147 Diagnosis of masked and white-coat hypertension, 147 Definition of morning hypertension, 148 Definition of nocturnal hypertension, 150 When to use HBPM and ABPM, 150 Clinically suspected SHATS, 152 Cardio-ankle vascular index (CAVI), 154 Coupling study, 154 How to measure home BP, 155 Nighttime home BP measurement schedule, 159 ABPM parameters, 162 24-hour BP, 166 Daytime BP and nighttime BP, 166 Morning BP parameters, 166 Nighttime BP parameters, 166 MBPS parameters, 166 Nighttime BP surge parameters, 166 Nighttime BP dipping parameters, 167 ABPM-defined hypertension subtypes, 167 Home and ambulatory BP-guided management of hypertension, 167 STEpwise-Personalized 24-hour BP control approach (STEP24 approach), 167 Targeting morning hypertension (Step 1), 167 Targeting nocturnal hypertension (Step 2), 171 Pressor mechanism-based nighttime BP management strategy, 173 4 BP targets, when to initiate antihypertensive therapy, and nonpharmacological treatment, 177 Clinical implications of antihypertensive treatment, 177 SPRINT and automated office BP, 177 Meta-analysis of antihypertensive trials, 177 When to initiate antihypertensive therapy, 178 Patient preference, 178 Sodium intake, 179 Other dietary requirements, 181 Exercise, 183 Sleep hygiene, 185 Housing condition, 185 Applications and algorithms to facilitate lifestyle modification: CureAPP, 187 5 Antihypertensive medication, 189 Concept of 24-hour BP lowering including nighttime and morning BPs, 189 Chronotherapy, 189 Antihypertensive drug choice, 190 Calcium channel blockers, 190 Amlodipine, 194 Nifedipine, 195 Cilnidipine, 197 Azelnidipine, 199 Angiotensin-converting enzyme inhibitors, 201 Angiotensin receptor blockers (ARBs), 201 Valsartan, 201 Telmisartan, 204 Candesartan, 204 Olmesartan, 205 Azilsartan, 206 Diuretics, 212 Alpha-adrenergic blockers and beta-adrenergic blockers, 214 Mineralocorticoid receptor blockers (MRB), 215 Angiotensin receptor-neprilysin inhibitor (ARNi), 217 Endothelin receptor antagonists (ERA), 221 Combination therapy, including single pill combinations, 222 First-line therapy, 222 Second-line therapy, 222 Clinical trials of antihypertensive combination therapy, 226 Management of resistant hypertension, 238 Third-line therapy, 238 Fourth-line therapy, 239 SGLT2 inhibitors, 240 SACRA study, 243 SHIFT-J study, 244 LUSCAR study, 248 Summary, 250 Other BP-lowering therapies, 252 Hypnotics, 252 XOR inhibitor, 252 Herbal medication, 253 6 Renal denervation, 255 Unsolved issues in the treatment of hypertension and the era for renal denervation, 255 Hypothesis of perfect 24-hour BP control by renal denervation, 256 History, 257 Advances in devices, 262 Symplicity spyral system (radiofrequency thermal ablation), 262 Iberis® system, 264 Paradise system (ultrasonic thermal ablation), 264 Peregrine system (trans-arterial alcohol injection), 265 Other energy modalities, 266 Evidence for renal denervation treatment of hypertension from Sham-controlled trials, 266 SPYRAL trials, 266 Radiance-Htn Solo study, 268 Evidence from Japanese populations, 269 The Global Symplicity Registry (GSR), 269 Safety of the renal denervation procedure, 270 24-hour BP lowering profile for cardiovascular protection, 270 Responders and clinical indications, 272 7 Blood pressure linked telemedicine and telecare, 278 Anticipation medicine, 278 Innovation technology, 280 Concept of “trigger” management, 282 Multisensors and the real-time hybrid Wi-SUN/Wi-Fi transmission system, 283 AI and anticipation models, 284 Development of wearable beat-by-beat (surge) BP monitoring, 285 Surge index, 292 Disaster cardiovascular prevention (DCAP) network, 294 Successful anticipation model of ICT-based BP control, 302 Disaster hypertension, 302 COVID-19 era, 305 8 Asia perspectives, 311 What is the HOPE Asia Network?, 311 HOPE Asia Network achievements, 312 Characteristics of cardiovascular disease in Asia, 315 Obesity and salt intake in Asia, 315 24-hour ambulatory BP profile in Asia, 320 Asia BP@Home Study, 325 References, 328 Index, 368
£61.70
John Wiley and Sons Ltd Mastering Structural Heart Disease
Book SynopsisTable of ContentsList of contributors Preface About the companion website Part I Structural Interventions for the Aortic Valve 1. Natural History and Hemodynamic assessment of aortic valvular disease 2. Pathology Insights of Aortic Valve Disease 3. The Top Ten Clinical Trials in Patients Undergoing Transcatheter Aortic Valve Implantation: The Evolution of a Transformative Therapy into Clinical Practice 4. Present and Future Generation Transcatheter Valves 5. Computed Tomography for Transcatheter Aortic Valve Replacement Planning – Current Perspectives and Future Directions 6. Optimal Selection of TAVR Devices 7. Transfemoral TAVR step by step (Balloon Expandable and Self Expandable Valves) 8. Balloon Aortic Valvuloplasty: Current Clinical Role and Technical Aspects 9. Challenging anatomy scenarios in TAVR 10. TAVR for the Bicuspid Aortic Valve 11. TAVR for Pure Native Valve Aortic Regurgitation 12. Aortic Valve in Valve Interventions 13. Prevention and Management of Coronary Occlusion in TAVR 14. Coronary artery disease and TAVR: Timing and patient selection for coronary intervention in patients that are planned for TAVR 15. Conduction Disturbances Associated with TAVR: Clinical impact and Techniques to Minimize 16. Management of conduction disturbances post Transcatheter Aortic Valve Replacement(TAVR) 17. TAVR mechanical complications prevention and management 18. Pathological insights of TAVR degeneration and thrombosis 19. Clinical Implications of Valve Thrombosis and early thickening: (Management of Antiplatelets and Anticoagulation post TAVR) 20. Transcatheter Aortic Valve Replacement and Stroke 21. Current Evidence Of Neuroprotection In TAVR 22. Difficult Transfemoral Access for TAVR and Bailout Techniques 23. Alternative Access for TAVR 24. Vascular Access, Complications and Closure Options for TAVR PART II Structural Interventions for the Mitral Valve 25. Natural History of Mitral Valve Disease 26. Hemodynamic Assessment of the Mitral Valve 27. Echocardiographic Assessment Prior to Mitral Valve Edge to Edge Repair 28. Intra procedural TEE for Mitral Valve Structural Interventions 29. Surgical Trials for Mitral Valvular Diseases 30. Surgical Techniques for Mitral Valve Repair 31. Structural Interventions for Mitral Stenosis 32. Transcatheter Edge To Edge Repair Trials : The EVEREST and COAPT Trials 33. TEER - The MitraClip Procedure 34. Transcatheter Edge to Edge Repair Challenging Anatomy & MitraClip Tips and Tricks 35. MitraClip complications : Prevention and Management 36. CT Imaging for TMVR 37. Transcatheter Mitral Valve in Valve ; Valve in MAC and Valve in Ring 38. Transcatheter Mitral Valve in Valve : Technical Considerations and Step by Step 39. Transeptal systems for TMVR and Transcatheter Devices for Mitral Annuloplasty 40. Tethered Self Expanding TMVR Systems (Tendyne) 41. Self Expanding TMVR systems. Intrepid Valve PART III Structural Interventions for the Tricuspid Valve 42. Natural History and hemodynamic assessment of Tricuspid Valve Diseases 43. Indications and Outcomes for Surgical Tricuspid Valve Repair 44. Intraprocedural Imaging for Tricuspid Valve Interventions 45. Transcatheter Tricuspid Valve Devices Landscape 46. Progress in Transcatheter Tricuspid Valve Replacement 47. Tricuspid Valve in Valve and Valve in Ring 48. Heterotopic Caval valve implantation (CAVI) PART IV Structural Interventions for Management of Perivalvular Leaks 49. Aortic PVL Closure: Techniques and Devices for Surgical and Transcatheter Prosthesis 50. Mitral Perivalvular Leak Closure: Imaging and Interventional Approaches PART V Left Atrial Appendage Closure 51. Current indications of LAA closure 52. Imaging for LAA interventions 53. Devices for Left Atrial Appendage Closure 54. LAA Technique and Challenging Scenarios 55. Preventing and Managing Complications of LAA Closure 56. Natural History of Hypertrophic Cardiomyopathy 57. Alcohol Septal Ablation in HCM 58. Transcatheter Edge to Edge Repair for Hypertrophic Cardiomyopathy 59. Interatrial Shunt Creation PART VII Selected Adult Congenital Structural Interventions 60. Shunts Hemodynamics and Calculations 61. PFO Closure 62. ASD Closure 63. VSD Closure 64. Percutaneous Treatment of Aortic Coarctation 65. Pulmonic Valve Interventions PART VIII Miscellaneous 66. Hemodynamic Pearls in Adult Structural Heart Disease 67. Closure of Coronary Artery Fistulas 68. Renal Denervation 69. Acute Pulmonary Embolism Interventions: Data and Indications 70. Acute pulmonary embolism intervention: Devices and Techniques 71. ECMO for Structural Interventions 72. Best Practices for Mechanical Circulatory Support with Impella for Acute Myocardial Infarction Cardiogenic Shock and Selected Structural Interventions 73. Transcatheter Interventions for Aortic Valve Insufficiency in Patients with Left Ventricular Assist Device (LVAD) Index
£142.50
John Wiley & Sons Inc Medical Instrument Design and Development
Book SynopsisThis book explains all of the stages involved in developing medical devices; from concept to medical approval including system engineering, bioinstrumentation design, signal processing, electronics, software and ICT with Cloud and e-Health development. Medical Instrument Design and Development offers a comprehensive theoretical background with extensive use of diagrams, graphics and tables (around 400 throughout the book). The book explains how the theory is translated into industrial medical products using a market-sold Electrocardiograph disclosed in its design by the Gamma Cardio Soft manufacturer. The sequence of the chapters reflects the product development lifecycle. Each chapter is focused on a specific University course and is divided into two sections: theory and implementation. The theory sections explain the main concepts and principles which remain valid across technological evolutions of medical instrumentation. The Implementation sections show how the theoryTable of ContentsForeword xv Preface xvii Acknowledgment xxi 1 System Engineering 1 Chapter Organization 1 Part I: Theory 4 1.1 Introduction 4 1.2 Problem Formulation in Product Design 4 1.3 The Business Context for Design 6 1.4 The Engineering Product Design Process 10 1.5 System-subsystem Decomposition 15 1.6 The Product Development Life Cycle 21 1.7 Project Management in Product Design 24 1.8 Intellectual Property Rights and Reuse 30 Part II: Implementation 32 1.11 The ECG: Introduction 32 1.11.1 The ECG’s diagnostic relevance 32 1.11.2 ECG Types 33 1.12 The ECG Design Problem Formulation 34 1.13 The ECG Business Plan 36 1.13.1 Market Size and Trend 37 1.13.2 Core and Distinctive Features 38 1.14 The ECG Design Process 40 1.14.1 Transverse Activities of the ECG Design Process 43 1.14.2 Core Activities of the ECG Design Process 44 1.15 ECG System–subsystem Decomposition 44 1.15.1 Hardware Platform Decomposition 45 1.15.2 Software Application Decomposition 45 1.16 ECG Product Life Cycle 46 1.16.1 Overcoming Risk of Inadequate Visualization of ECG Signal 47 1.16.2 Overcoming Risk of Error Fixing in System Integration 50 1.16.3 Overcoming Risks for Non-stable/Unfeasible Requirements 50 1.17 The ECG Development Plan and Project Management 51 1.18 IPR and Reuse Strategy for the ECG 55 References 57 2 Concepts and Requirements 59 Chapter Organization 59 Part I: Theory 61 2.1 Introduction 61 2.2 The Medical Instrumentation Approach 62 2.3 Extraction of Physiological Parameters 67 2.4 Pressure and Flow 70 2.4.1 Blood Pressure 72 2.4.2 Blood Flow and Hemodynamics 74 2.5 Biopotential Recording 79 2.6 Electroencephalography 81 2.7 Electromyography 85 Part II: Implementation 88 2.8 Introduction 88 2.9 Requirements Management 89 2.10 Medical Instruments Requirements and Standards 91 2.11 ECG Requirements 94 2.12 The Patient Component 96 2.12.1 The Heart’s Pumping Function and the Circulatory System 96 2.12.2 Heart Conduction ‘Control’ System 97 2.13 The ECG Method for Observation 99 2.13.1 Recording the Heart’s Electrical Signals 99 2.13.2 ECG Definition and History 103 2.13.3 ECG Standard Method of Observation 103 2.14 Features of the Observations 108 2.14.1 ECG Signal 108 2.14.2 Clinically Significant Signal 110 2.14.3 Power Line Noise 117 2.14.4 Isoelectric Line Instability 118 2.14.5 Muscle Artifacts 119 2.15 Requirements Related to Measurements 119 2.16 Safety Requirements 126 2.16.1 EMC Performance 128 2.17 Usability and Marketing Requirements 131 2.18 Environment Issues 132 2.19 Economic Requirements 134 References 135 3 Biomedical Engineering Design 137 Chapter Organization 138 Part I: Theory 139 3.1 Design Principles and Regulations 139 3.2 General Design System Model 141 3.3 Pressure and Flow Instruments 142 3.3.1 Blood Pressure Instruments 144 3.3.2 Flow Measurements 146 3.3.3 Measuring Oxygen Concentration 147 3.4 Biopotential Instruments 148 3.4.1 Electroencephalographs 148 3.4.2 Electromyographs 151 3.5 The Design Process 152 3.5.1 The Conceptual Design 155 3.5.2 System-wide Design Decisions 156 3.5.3 System Architectural Design 157 3.5.4 Risk Management 157 Part II: Implementation 160 3.6 ECG-wide Decisions 160 3.6.1 The Gamma Cardio CG Use Case 160 3.6.2 Human Factors and the User Interface Design 161 3.6.3 Patient Interface: the Biopotential Electrodes 167 3.7 The ECG System Architectural Design 170 3.7.1 Subsystem Identification 170 3.7.2 The Communication Interfaces 171 3.7.3 Acquisition Hardware Requirements 174 3.7.4 Firmware Requirements 176 3.7.5 Software Application Requirements 177 3.7.6 Concept of Execution among Subsystems 178 3.8 Gamma Cardio CG Technical File Structure 179 References 180 4 Signal Processing and Estimation 181 Chapter Organization 181 Part I: Theory 184 4.1 Discrete Representations of Analog Systems 184 4.2 Discrete Fourier Transform 189 4.2.1 Discrete Fourier Transform Statistics 194 4.3 Estimation Theory Framework 197 4.3.1 Minimum Mean Square Error Estimate 199 4.3.2 Minimum Mean Absolute Error Estimate (MMAE) 201 4.3.3 Maximum A Posteriori (MAP) Probability Estimate 202 4.3.4 Maximum Likelihood Estimation (MLE) 203 4.4 Performance Indicators 204 4.4.1 Efficient Estimators 208 4.4.2 Fisher’s Information Matrix 209 4.4.3 Akaike Information Criterion 212 Part II: Implementation 214 4.5 Analog to Digital Conversion 214 4.5.1 Indirect Sampling versus Direct Sampling 214 4.5.2 Quantizer Design 216 4.6 Signal Denoising 221 4.6.1 White Gaussian Signals in Additive White Gaussian Noise 221 4.6.2 Denoising of Gaussian Cyclostationary Signals 222 4.6.3 MMSE Digital Filter 222 4.7 Time of Arrival Estimation 224 References 229 5 Applied Electronics 231 Chapter Organization 231 Part I: Theory 233 5.0 Architectural Design 235 5.1 Sensors 236 5.2 Circuit Protection Function 243 5.2.1 Johnson Noise 246 5.2.2 Transient Voltage Suppressors 247 5.2.3 RF Filter Circuit Protection 248 5.2.4 Circuit Frequency Response 251 5.3 Buffer Stage 254 5.3.1 Operational Amplifiers 256 5.4 Analog Signal Processing 258 5.4.1 Summing Amplifier Circuit 259 5.4.2 Analog Signal Switching 260 5.5 Interference and Instrumentation Amplifiers 262 5.5.1 Eliminating In-band Interference 262 5.5.2 Patient Model 267 5.5.3 The ECG Model 268 5.5.4 Right Leg Connection 270 5.5.5 Right Leg Driver Circuit 272 5.6 Analog Filtering 273 5.6.1 Frequency Domain 273 5.6.2 Analog versus Digital Filtering 278 5.7 ADC Conversion 279 5.8 Programable Devices 285 5.9 Power Module 289 5.9.1 Power Sources 290 5.9.2 Electrical Safety and Appliance Design 294 5.9.3 Power Module Design 298 5.10 Baseband Digital Communication 301 5.10.1 Data Transmission Elements 302 Part II: Implementation 313 5.20 Gamma Cardio CG Architecture 313 5.20.1 ECG Design Choices 314 5.20.2 Gamma Cardio CG Complete Scheme 317 5.21 ECG Sensors 317 5.22 Gamma Cardio CG Protection 321 5.23 Gamma Cardio CG Buffer Stage 325 5.24 The Lead Selector 327 5.24.1 Calibration 331 5.25 ECG Amplification 332 5.25.1 ECG Circuits 333 5.25.2 Input Dynamic Range: Requirement Demonstrations 337 5.25.3 Gain Error: Requirement Demonstrations 338 5.26 Analog Filtering 339 5.27 The ADC Circuit 342 5.28 Programable Devices 346 5.28.1 Circuit Design 347 5.28.2 The Clock 348 5.29 Power Module 351 5.29.1 Power Module Circuit 353 5.30 Communication Module 353 Conclusion 357 References 358 6 Medical Software 359 Chapter Organization 359 Part I: Theory 361 6.1 Introduction 361 6.1.1 Intrinsic Risks and Software Engineering 362 6.1.2 Main Concepts in Software Development 363 6.1.3 Regulatory Requirements for Software 364 6.2 The Process: a Standard for Medical Software 365 6.2.1 IEC/EN 62304 Overview 365 6.2.2 Risk Analysis for Hardware and Software Design 368 6.2.3 Software Safety Classification 370 6.2.4 System Decomposition and Risks 371 6.2.5 Impact of Safety Classification 372 6.2.6 Soup 372 6.3 Risk Management Process 374 6.3.1 Risk Management in Software 376 6.3.2 Risk Management for Medical Instrument Software 377 6.4 Software Development Process 379 6.4.1 Software Development Planning 380 6.4.2 Software Requirements Analysis 381 6.4.3 Software Architectural Design 382 6.4.4 Detailed Software Design 385 6.4.5 Software Unit Implementation and Verification 385 6.4.6 Software Integration and Integration Testing 387 6.4.7 Software System Testing 388 6.4.8 Software Release 388 6.5 Software Configuration Management Process 389 6.6 Software Problem Resolution Process 391 6.7 Software Maintenance Process 392 6.8 Guidelines on Software Design 393 6.8.1 Definitions 395 6.8.2 Basic Recommendations 396 6.8.3 Software Core Services 396 6.8.4 Defensive Programing 398 Part II: Implementation 400 6.9 System Decomposition 400 6.9.1 Gamma Cardio CG Use Case 400 6.9.2 System Decomposition 401 6.10 Risk Management 402 6.11 Software Application 403 6.11.1 Software Requirements 403 6.11.2 Architectural Design 407 6.11.3 Elaboration Module 409 6.12 Firmware 411 6.12.1 Firmware Requirements 411 6.12.2 Architectural Design 413 6.12.3 Automatic Test Capability 416 References 418 7 C-health 419 Chapter Organization 420 Part I: Theory 421 7.1 Introduction 421 7.1.1 The Assessment Framework 421 7.1.2 Assessment Framework for the Health Sector 422 7.2 The Cloud Computing Model 426 7.2.1 Basics of Cloud Computing 426 7.2.2 Cloud Platforms 428 7.2.3 Services in the Cloud 430 7.2.4 The Cloud Shape 432 7.2.5 Features of the Clouds 434 7.3 e-Health 435 7.3.1 Interoperability in e-Health 437 7.4 Electronic Health Record (EHR) 442 7.5 c-Health 445 Part II: Implementation 449 7.6 Telecardiology 450 7.6.1 Application Scenario 450 7.7 Telecardiology Technology 451 7.8 Workflow in Telecardiology 455 7.8.1 Basic Workflows 455 7.8.2 Alternative Workflows 457 7.8.3 Where and When Telecardiology Can Be Used 460 7.9 Risks of Telecardiology 463 References 465 8 Certification Process 467 Chapter Organization 467 Part I: Theory 469 8.1 Certification Objectives and Processes 469 8.1.1 Certification, Standards and Definitions 470 8.2 Regulations, Standards and Organizations 474 8.2.1 Technical Standards for Medical Devices 477 8.2.2 European Context 478 8.3 Basic Protection Concepts 480 8.3.1 Protection Against Electric Shock 480 8.3.2 Insulation 484 8.3.3 Degree of Protection Provided by Enclosures 485 8.4 Verification of Constructional Requirements 486 8.4.1 Choice of Safety Critical Materials and Components 486 8.4.2 Creepage Distances and Air Clearances 489 8.4.3 Markings 490 8.4.4 Conductors 492 8.4.5 Connections to the Power Supply 494 8.4.6 Fire Enclosure 495 8.5 Medical Equipment Safety Tests 495 8.5.1 Leakage Current 497 8.5.2 Heating 499 8.5.3 Dielectric Strength 500 8.5.4 Stability and Mechanical Strength 500 8.5.5 Abnormal Operating and Fault Conditions 501 8.5.6 Continuity of Protective Earthing 502 8.5.7 Residual Voltage 503 8.5.8 Voltage on the Accessible Parts 503 8.5.9 Energy Stored – Pressurized Part 503 8.5.10 Current and Power Consumption 504 8.6 Electromagnetic Compatibility 504 8.6.1 Emissions 506 8.6.2 Immunity 511 8.6.3 The Test Report 513 Part II: Implementation 515 8.11 The Process 515 8.11.1 Device Description 516 8.11.2 Medical Device Classes 516 8.11.3 EU Conformity Assessment 519 8.11.4 Risk Management Deliverable 520 8.11.5 The Technical File 527 8.12 Regulatory Approaches to Medical Device Market Placement 537 8.13 Basic Concepts in Device Implementation 540 8.13.1 Protection Against Electric Shock 541 8.13.2 Insulation 541 8.13.3 Enclosure IP Protection 544 8.14 Verification on Design Performance 544 8.14.1 Safety-critical Materials 544 8.14.2 Creepage and Air Clearance 545 8.14.3 Other Verifications 545 8.15 Safety Tests 546 8.15.1 Leakage Current 546 8.15.2 Heating 546 8.15.3 Other Safety Tests 547 8.16 Electromagnetic Compatibility 548 8.16.1 Emission 549 8.16.2 Immunity 550 References 554 Summary of Regulations and Standards 555 Index 559
£95.90
John Wiley and Sons Ltd ECGs for Acute Critical and Emergency Care Volume
Book SynopsisTable of ContentsForeword v Preface vi Dedications viii Part 1 Case histories 3 ECG interpretations and comments 53 Part 2 Case histories 83 ECG interpretations and comments 133 Appendix A: Differential Diagnoses 159 Appendix B: Commonly used abbreviations 161 Index 162
£47.49
John Wiley & Sons Electronic Fetal Heart Rate Monitoring The 5Ti
Book Synopsis
£70.20
John Wiley and Sons Ltd Heart Failure
Book SynopsisNow there is an up-to-date guide for optimizing pharmacologic therapy in treating patients with heart failure. Reflecting current practice at leading medical centers, Heart Failure: Pharmacologic Management provides both the biologic and pathologic underpinnings of each pharmacologic agent in current use. It also supplies detailed discussions of the clinical investigations that support current understanding of the risks and benefits associated with the use of these drugs. Thorough references make the book useful to the novice as well as the experienced clinician. Initial chapters focus on agents that are considered standard care: diuretics ACE inhibitors angiotensin receptor antagonists aldosterone antagonists beta-blockers The discussion moves to agents currently Table of ContentsContributors. Introduction. 1. Diuretics in congestive heart failure (Alicia Ross, Ray E. Hershberger and David H. Ellison). 2. Use of digoxin in the treatment of heart failure (Deborah DeEugenio and Paul J. Mather). 3. Renin-angiotensin system and angiotensin converting enzyme inhibitors in chronic heart failure (Rimvida Obeleniene and Marrick Kukin). 4. Angiotensin receptor blockers in the treatment of hart failure (Anita Deswal and Douglas L. Mann). 5. Beta blockers (Peter F. Robinson and Michael R. Bristow). 6. Aldosterone antagonism in the pharmacological management of chronic heart failure (Biykem Bozkurt). 7. Inotropic therapy in clinical practice (Sharon Rubin and Theresa Pondok). 8. Antiarrhythmic therapy in heart failure (Igino Contrafatto and Leslie A. Saxon). 9. Treating the hypercoagulable state of heart failure: modifying the risk of arterial and venous thromboembolism (Geno J. Meril and Hoard H. Weitz). 10. Vasodilator and nitrates (Abdul Al-Hesayen and John D. Parker). 11. Natriuretic peptides fro the treatment of heart failure (Jonathan D. Sackner-Bernstein, Hal Skopicki and Keith D. Aaronson). 12. Immune modulatory therapies in heart failure: using myocarditis to gain mechanistic insights (Grace Chan, Koichi Fuse, Mei Sun, Bill Ayach and Peter P. Liu). 13. The role of vasopressin and vasopressin antagonists in heart failure (Olaf Hedrich, Maervin A. Konstam and James Eric Udelson). 14. Role of erythropoietin in the correction of anemia in patients with heart failure (Revecca P. Streeter and Donna M. Mancini). 15. Endothelin antagonism cardiovascular disease (Srinivas Murali). 16. Pharmacogenetics (Richard Sheppard and Dennis M. McNamara). 17. Management of diastolic dysfunction (Arthur M. Feldman and Bonita Fakner). 18. Multidrug pharmacy for treatment of heart failure: an algorithm for the clinician (Mariell Jessup). Index.
£97.16
John Wiley and Sons Ltd Simplified Interpretation of Pacemaker ECGs
Book SynopsisOffers a description of pacemaker ECG interpretations. This book includes: a refresher course on basic ECG interpretation with an overview of the conduction system of the heart; a review of the hardware associated with pacing; and, an explanation and discussion of the sensing and pacing function.Table of ContentsForeword. Preface. Acknowledgments. Section I - The Basics. Chapter 1. Basic ECG Refresher. Chapter 2. What Is a Pacemaker?. Chapter 3. Pacemaker System and Cardiac Anatomy. Chapter 4. The Hardware. The Pacemaker Generator. The Pacemaker Lead. The Pacemaker Programmer. The Pacemaker Magnet. Chapter 5. Electronics 101. The Electrogram. Chapter 6. Sensing and Sensitivity. Chapter 7. Pacing and Capture. Chapter 8. Rate Versus Interval. Chapter 9. The Code and Mode. Section II - The Modes. Chapter 10. VVI Pacing. VVI Timing. Rate Modulation. Magnet Mode (VOO). Chapter 11. AAI Pacing. AAI Timing. Rate Modulation. Magnet Mode (AOO). Chapter 12. DDD Pacing. DDD Timing. Upper Rate Behavior. Pacemaker-Mediated Tachycardia. Mode Switching. Rate Modulation. Magnet Mode (DOO). Chapter 13. VDD Pacing. VDD Timing. Upper Rate Behavior/Mode Switching. Magnet Mode (VOO). Chapter 14. DDI Pacing. DDI Timing. Rate Modulation. Magnet Mode (DOO). Chapter 15. DVI Pacing. DVI Timing. Rate Modulation. Magnet Mode (DOO). Section III - Unusual Pacing Situations and Alternate Applications of Permanent Pacing. Chapter 16. Unusual Pacing Situations. Diagnostic Pacing Modes. Pacing to Prevent Atrial Fibrillation. Transcutaneous Pacing. Automatic Threshold Determination. Diagnosis of Myocardial Infarction. Effects of Electric Cautery on Pacing. Chapter 17. Alternate Applications of Permanent Pacing. Pacing for Hypertrophic Obstructive Cardiomyopathy. Pacing for Ventricular Tachycardia. Pacing for Heart Failure. Pacing for Syncope. Section IV - Case Studies. Chapter 18. Case Studies Part A. Case Studies 1 - 7. Chapter 19. Case Studies Part B. Case Studies 8 - 43. Index
£57.90
John Wiley and Sons Ltd Primary Care Cardiology
Book SynopsisManagement of cardiovascular disease has changed dramatically, and the second edition of Primary Care Cardiology provides a comprehensive review of new treatment strategies. By emphasizing the basic principles critical to understanding and managing heart disease while putting recent developments in the field into perspective, this practical guide also serves as a curriculum for doctors studying for board examinations or re-certification. Helpful features include: Over 50 classic cardiovascular diagrams 50 summary tables for quick reference Concise overview of the vast body of cardiovascular literature Straightforward, readable tone Convenient pocket-size for rapid review Written for primary care physicians, this book is also perfect for physician assistants and nurse practitioners.Trade Review“I really cannot find many faults with this text. Primary Care Cardiology is a wonderful book to refresh your knowledge about cardiology. I would recommend it to anyone who has a desire to learn more about cardiology in a clinically relevant way. This book gives you practical knowledge and the applications of that knowledge.” – MD, Cardiology Fellow, Lubbock, Texas “I felt that the author provided clear, useful explanations for things that I have to date not heard explained so well, and I am continually impressed by the practical and applicable nature of the material covered in this text. It seems very relevant and appropriate for the primary care practitioner as well as the primary care PA/NP.” – RN, FNP, PA-C, Physician Assistant, La Jolla, California “Previously, I used multiple sources for all this information. Primary Care Cardiology compiles a lot of information in one volume that I haven’t seen pulled together in this same way before, and things are summarized in this text that I have not seen all in one source elsewhere. Overall, I think this book is an “A”!” - MD, MPH, Instructor-Fellow, Family Medicine/Pediatrics, Denver, Colorado “Primary Care Cardiology is a nice review of cardiovascular disease and the enormous literature that supports recent treatment recommendations. It seems like a practical guide for the majority of what one would encounter in the primary care setting. This is an important book that will serve as a nice brief review for the busy practitioner preparing for a board exam, or just searching to brush up on this critical topic.” – MD, MSc, Assistant Professor of Medicine, Kansas City, Kansas “Primary Care Cardiology is current and up-to-date. The author has been in clinical practice for many years and draws upon that valuable and relevant experience. He provides helpful examples from his own experience and validates his hypothesis with years of results, bridging the gap between theory and practical application very effectively. As I read the text I feel like I can trust the advice given.” – RN, FNP, PA-C, Physician Assistant, La Jolla, California “My overall impression of Primary Care Cardiology is that some valuable additions have been made to this book during the revision process. The information is up-to-date and concise. I especially appreciate the practical, less-formal tone.” – MD, MPH, Instructor-Fellow, Family Medicine/Pediatrics, Denver, Colorado “The main strength of the book is the way it simplifies topics in a way that makes them easy to understand without making you feel like you are reading a remedial text. The combination of the text and the figures really makes it easy to understand these difficult concepts. Taylor’s book could be read by anyone from a medical student or nurse to a practicing physician and be equally readable and helpful.” – MD, Cardiology Fellow, Lubbock, TexasTable of ContentsReviewers. Preface. Congestive Heart Failure Caused by Systolic Dysfunction Disorders of Ventricular Filling: Diastolic Heart Failure, Restrictive Cardiomyopathy, and Pericardial Disease Atherosclerosis: Mechanisms, Lipid Disorders, and Screening for Preclinical Disease Angina Pectoris: Evaluation of Chest Pain and the Management of Angina Pectoris and Acute Coronary Syndromes Myocardial Infarction Cardiac Arrhythmias and Syncope Valvular Heart Disease Hypertension, Aortic Disease and Other Medical Illnesses with Cardiovascular Effects Cardiology Consults: Preoperative Care of the Patient Having Noncardiac Surgery Isolated Right Heart Failure Congenital Heart Disease Seen in Adults Pregnancy and Heart Disease End-of-Life Decisions and Palliative Care for Patients with Heart Disease . Index
£44.60
John Wiley and Sons Ltd Diagnosis and Management of Hypertrophic
Book SynopsisPresents a compendium of information regarding the complexities of clinical and genetic diagnosis, natural history, and management of hypertrophic cardiomyopathy (HCM) as well as related issues impacting the health of trained athletes. This book provides a single comprehensive source of information concerning HCM.Table of ContentsForewordPravin Shah, MD. Dedication and Acknowledgments. List of Contributors. 1. Phenotypic Expression and Clinical Course of Hypertrophic Cardiomyopathy. Barry J. Maron, MD2. Genetic Mutations that Remodel the Heart Carolyn Y. Ho, MD and Christine E. Seidman, MD. 3. Genetic Basis and Genotype-Phenotype Relationships in Familial Hypertrophic Cardiomyopathy. Albert A. Hagège, MD, PhD, Ketty Schwartz, PhD, Michel Desnos, MD, and Lucie Carrier, PhD. 4. Historical Perspective, Mechanism, and Clinical Significance of Left Ventricular Outflow Tract Obstruction in Hypertrophic CardiomyopathyMartin S. Maron, MD, Iacopo Olivotto, MD, and Barry J. Maron, MD. 5. Hypertrophic Cardiomyopathy with Latent (Provocable) Obstruction: Pathophysiology and Management. E. Douglas Wigle, MD, Maria Eriksson, MD, PhD, Paul Rakowski, David Focsaneanu, Cairrine Sloggett, RN, Anna Woo, MD, and Harry Rakowski, MD. 6. Pathophysiology and Clinical Consequences of Atrial Fibrillation in Hypertrophic Cardiomyopathy. Iacopo Olivotto, MD, Barry J. Maron, MD, and Franco Cecchi, MD. 7. Other Modes of Disability or Death Including Stroke, and Treatment Strategies in Hypertrophic CardiomyopathyFranco Cecchi, MD, Iacopo Olivotto, MD, and Barry J. Maron, MD. 8. Disturbed Vascular Control in Hypertrophic Cardiomyopathy: Mechanisms and Clinical Significance. Ross Campbell, BSc, Jayne A. Morris-Thurgood, PhD, and Michael P. Frenneaux, FRCP, FRACP. 9. Clinical Significance of Diastolic Dysfunction and the Effect of Therapeutic Interventions. Sandro Betocchi, MD and Raffaella Lombardi, MD. 10. Value of Exercise Testing in Assessing Clinical State and Prognosis in Hypertrophic Cardiomyopathy. Sanjay Sharma, MRCP, MD. 11. Pathophysiology and Significance of Myocardial Ischemia in Hypertrophic Cardiomyopathy. Rajesh Thaman MBBS, MRCP, Bhavesh Sachdev MBBS, MRCP, and Perry M. Elliott MBBS, MD, MRCP. 12. Hypertrophic Cardiomyopathy in Japan: Clinical, Morphologic and Genetic Expression. Yoshinori Doi, MD, PhD, Hiroaki Kitaoka, MD, Nobuhiko Hitomi, MD, Naohito Yamasaki, MD, Yoshihisa Matsumura, MD, Takashi Furuno, MD, and Barry J. Maron, MD. 13. Prevalence, Prevention and Treatment of Infective Endocarditis in Hypertrophic CardiomyopathyPaolo Spirito, MD, Marco Piccininno, MD, and Camillo Autore, MD. 14. Pharmacologic Treatment of Symptomatic Hypertrophic CardiomyopathyMark V. Sherrid, MD and Ivan Barac, MD. 15. Obstructive Hypertrophic Cardiomyopathy: Results of Septal Myectomy Gordon K. Danielson, MD and Joseph A. Dearani, MD. 16. US Perspectives on the Role of Dual-Chamber Pacing in Patients with Hypertrophic CardiomyopathyPaul Sorajja, MD, Steve R. Ommen, MD, and Rick A. Nishimura, MD. 17. Dual-Chamber Pacing for Hypertrophic Obstructive Cardiomyopathy Xavier Jeanrenaud, MD, and Lukas Kappenberger, MD. 18. Alcohol Septal Ablation Hubert Seggewiss, MD Prof. Angelos Rigopoulos, MD, Lothar Faber, MD, and Peer Ziemssen, MD. 19. Alcohol Septal Ablation in the Treatment of Hypertrophic Obstructive Cardiomyopathy: A Seven-Year Experience. Horst Kuhn, MD, Thorsten Lawrenz, MD, Frank Lieder, MD, Frank H. Gietzen, MD, Ludger Obergassel, MD, Claudia Strunk-Muller, MD, Berit Stolle, MD, and Christian H. Leuner, MD. 20. Role of Septal Ablation in a Surgical CenterHarry M. Lever, MD. 21. Molecular and Clinical Tools for Sudden Death Risk Assessment in Hypertrophic Cardiomyopathy. Asifa Quraishi MB, MRCP, Mohammad S. Hamid MB, MRCP, and William J. McKenna MD, FRCP. 21A. In Memorium: Asifa Quraishi. 22. Risk Stratification For Sudden Death in Hypertrophic Cardiomyopathy: Extreme Left Ventricular Hyptertrophy as a New Indicator of Risk. Paolo Spirito, MD and Barry J. Maron, MD. 23. Implantable Defibrillator for Prevention of Sudden Death in Hypertrophic Cardiomyopathy. Barry J. Maron, MD, Win-Kuang Shen, MD, and Paolo Spirito, MD. 24. Hypertrophic Cardiomyopathy and Other Causes of Sudden Death in the Trained Athlete: An Electrophysiologist Perspective on the Management of Benign and Not So Benign Arrhythmias. N.A. Mark Estes III, MD, Paul J. Wang, MD, Munther K. Homoud, MD, and Mark S. Link, MD. 25. The Athlete’s Heart, the Athlete’s ECG, and Differential Diagnosis with HCM and Other Cardiomyopathies. Antonio Pelliccia, MD and Barry J. Maron, MD. 26. Importance of Congenital Coronary Artery AnomaliesCristina Basso, MD, PhD, Domenico Corrado, MD, and Gaetano Thiene, MD. 27. Arrhythmogenic Right Ventricular Cardiomyopathy and Hypertrophic Cardiomyopathy: Identification with the Italian Preparticipation Athlete Screening Program. Domenico Corrado, MD, Cristina Basso, MD, PhD, Maurizio Schiavon, MD, and Gaetano Thiene, MD. 28. Cardiovascular Causes of Sudden Death, Preparticipation Screening, and Criteria for Disqualification in Young AthletesBarry J. Maron, MD. 29.Sudden Death Due to Chest Blows (Commotio Cordis). Mark S. Link, MD, N. A. Mark Estes III, MD, and Barry J. Maron, MD. 30. Naturally Occurring Animal Models of Cardiovascular Disease Causing Premature Death. Philip R. Fox, DVM. 31. The Role of the Internet and Patient Support Groups for Those Living with Hypertrophic Cardiomyopathy. Lisa Salberg. AfterwordRobert Jon Pensack, MD. Index
£133.16
